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 In 1988, two highly homologous groups of genes were identified in human epidermal 
keratinocytes. Their expression levels were increased both in response to UV-light and during 
epidermal differentiation. The encoded proteins were small, contained repeated sequences 
and were exceptionally rich in proline residues and were therefore designated as small 
proline-rich (SPRR) proteins. Today, 11 members of this gene family are known. They are 
categorised into four groups, based on sequence homology and the amount of internal 
repeats. During the establishment of the epidermal barrier SPRR proteins are expressed in 
the upper layers of the epidermis. Their well-known function in the skin’s barrier formation 
and adaptation is reviewed in Chapter I. 
The various SPRR family members are differentially expressed in squamous epithelia 
and respond differently to external stressors. Their promoter regions contain a dedicated 
mixture of transcription factor binding sites that allows this divergent gene expression. In 
Chapter II the cooperative gene regulation by two of these transcription factors, namely 
Skn-1a and Ese-1, is presented. 
A few years ago, SPRR proteins were unexpectedly found in all major tissues, ranging 
from gut and brain to liver and heart. While analysing wounded skin we found an important 
role for the SPRR proteins in the healing process. Directly after wounding, reactive oxygen 
species (ROS) are generated as the initial signal that activates the immune response and as 
a defence against invading bacteria. However, ROS are also harmful for the surrounding 
tissue and impede subsequent wound closure. SPRR proteins can directly reduce the toxic 
ROS levels in the adjacent cells and thereby promote cell migration. This study is described 
in Chapter III. Apparently, this novel role in wound healing is far more widespread than 
their established function in skin cornification.  
In Chapter IV, the antioxidant properties of the SPRR proteins were extended to 
non-wounded skin. As the amount of oxygen in air is almost 7 times higher than within our 
body a specialised barrier is required to protect us from oxidation. We showed that the SPRR 
proteins, during their conventional role in the formation of a mechanical and permeability 
barrier, also provide an antioxidant barrier to our skin. Thus, the SPRR proteins directly 
function as our first line of defence against ROS. 
In Chapter V, a screen for SPRR protein interactions partners is presented. The role 
of some identified proteins confirmed a role of SPRRs in cornification and antioxidant 
function, but also revealed a role in DNA-binding, which was confirmed by direct 
experimentation. Furthermore, a molecular model explaining how the intracellular oxidation 
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SPRR proteins: from epidermal cornification to global ROS detoxification 
and wound healing 
 
Protective skin barrier 
At the skin surface, the epidermis functions as primary barrier against a continuous 
challenge of various environmental hazards and is essential for mammalian life19,84. It 
excludes harmful microorganisms, withstands mechanical and chemical assaults, and 
protects our body from dehydration19,57. It is a thin multi-layered compartment comprised of 
a basal-, spinous-, granular-, and cornified layer, respectively (Figure 1). The major barrier 
property resides within the cornified layer44, a layer of dead flattened cells on the skin 
surface. These cells are in direct contact with atmospheric oxygen and constitute a first line 
of defence163. They contain a special structure beneath the plasma membrane, termed the 
cornified cell envelope (CE), which is comprised of cross-linked proteins and lipids68,130,147. 
Although these cells will eventually shed off, the skin’s barrier is constantly self-renewed39,98.  
 
 
Figure 1: Protective epidermal barrier. A, Graphical representation of a cross section of the multi-
layered human skin. The main barrier resides within the outermost cornified layer. These cells contain 
an insoluble protein structure of cross-linked cornified envelope precursor proteins, such as involucrin, 
loricrin and the SPRR protein family members. B-D, Cultured human skin equivalents stained by 
immunohistochemistry for SPRR1 (B), SPRR2 (C), and Ki67 (D). SPRR protein expression (brown-
staining) is observed in the upper epidermal layers while Ki67 (a marker for dividing cells) is restricted 




Within the innermost basal layer a population of mitotically active keratinocytes 
(Figure 1D) provides a continuous supply of new cells under both homeostatic and injury 
conditions57,198. Keratinocytes from this basal layer divide asymmetrically to generate two 
daughter cells of which one retains a proliferative basal cell character while the second 
becomes a committed suprabasal cell101. This cell undergoes a process called cornification 
and starts to migrate upwards through the different skin layers in a period of 4 to 5 weeks. 
Throughout this process the cell undergoes several morphological changes and at each stage 
of the cornification process a different subset of genes is expressed. During stage one 
(initiation), envoplakin154, periplakin153 and involucrin148, are expressed within the spinous 
layer. They are directed to the plasma membrane and initiate the assembly of the CE83,176. 
Subsequently, these proteins are cross-linked by transglutaminases (Figure 2)41,111. In the 
granular layer they are covalently attached to the desmosomal junctions to form a scaffold 
for other cornified envelope precursor proteins84,175. Concomitantly a complex series of lipids 
are synthesised (stage two; lipid-envelope formation). These lipids are coated around the 
protein envelope scaffold and ultimately form a 5 nm thick lipid envelope19,130. At stage three 
(reinforcement) more cornified envelope precursor proteins (e.g. loricrin123, filaggrin149, 
repetin100, trichohyalin104 and the small proline-rich (SPRR)18,60,86, late cornified envelope 
(LCE)77,116 or S10045 protein families) are cross-linked to the pre-existing scaffold. This 
protein envelope (of approximately 10 nm thick) together with the lipid envelop turns the CE 
into an extremely tough structure which still allows the high flexibility of our skin. 
 
 
Figure 2: Schematic overview of the protein cross-linking reaction by transglutaminases. Two CE 
proteins are cross-linked together via a lysine residue on protein 1 and a glutamine residue on protein 
2 by the calcium-dependent  transglutaminase enzyme. 
 
Epidermal Differentiation Complex 
Most of the cornified envelope precursor genes are located on a small region on 
human chromosome 1q21, also known as the epidermal differentiation complex (EDC)126. 
The genes in this region are co-ordinately regulated during the cornification process. For 
example, the single cornification genes involucrin and loricrin as well as the SPRR and LCE 




domains which are, due to their high lysine and glutamine content, used for 
transglutaminase cross-linking10. The internal domains do not show any sequence homology 
and are unique for each (specific type of) protein(s). Due to their common location on the 
EDC, their involvement in the cornification process and the high sequence homology of their 
external domains, it is generally believed that all genes in this region originated from 
duplications of a single ancestor gene which later has diverged10,190.  
Furthermore, the middle part of all above mentioned EDC genes contains typical 
repetitive sequences. The central domain of involucrin consists of 39 repeats of six different 
amino acids and the whole protein appears to originate from a single CAG repeat40. These 
repeats contain mostly charged residues, which makes involucrin a highly soluble 
protein40,189. The middle part of loricrin has one of the highest known contents of glycine 
residues which are configured in quasipeptide repeats. As a result, loricrin is an extremely 
flexible but also poorly soluble protein84,123. The SPRR family members all have proline-rich 
central domains (Figure 3). This family consists of 11 highly homologous members which are 
subdivided into four groups (Table 1). Each group contains a different amount of tandem 
repeats, varying by 8 or 9 amino acids in size. With an overall proline content of 
approximately 30%, the SPRR proteins have a very rigid protein backbone18,60. The group of 
LCE genes appear to be hybrids between loricrin and SPRR84.  
 
















SPRR1A 89 9,88 6 30,3 12,4 20,2 9 
SPRR1B# 89 9,89 6 29,2 12,4 18 9 
SPRR2A# 72 7,96 3 37,5 11,1 16,7 15,3 
SPRR2B 72 7,96 3 38,9 11,1 16,7 15,3 
SPRR2C* 72 7,94 3 34,7 11,1 15,3 15,3 
SPRR2D 72 7,9 3 37,5 11,1 16,7 16,7 
SPRR2E 72 7,85 3 38,9 11,1 16,7 18,1 
SPRR2F 72 7,8 3 36,1 11,1 16,7 18,1 
SPRR2G 73 8,1 3 39,7 9,6 13,7 15,1 
SPRR3# 169 18,1 16 22,5 11,8 10,1 4,7 
SPRR4# 79 8,7 4 16,5 13,9 29,1 8,9 
#Protein sequences, repeats, predicted secondary structure and diverse specific amino acids of 
SPRR1B, SPRR2A, SPRR3, and SPRR4 are represented in more detail in Figure 3. 
*Truncated translation due to premature stop codon. 
 
Barrier adaptation by SPRR 
The protein composition of the CE varies between different body sites. Although it 
always comprises a total of 85-90% loricrin and SPRR proteins, their relative molar ratio 




forestomach epithelium93,174. From a materials science point of view, these proteins form a 
composite which is responsible for the very high toughness of the outermost layer of our 
skin174. Since loricrin is poorly soluble and accumulates in granules in the cytoplasm, it 
requires cross-linking to the highly soluble SPRR proteins to translocate to the cell 
periphery20,172. By cross-linking the long flexible loricrin molecules with the short rigid SPRR 
proteins in different molar ratios the biomechanical properties of the CE can be regulated 
according to the tissue’s requirements18,174. 
 
Figure 3: Protein sequence of various SPRR family members. The characteristic SPRR-repeats in the 
central domain of the proteins are boxed. Global distributed cysteine residues (blue), proline residues 
within the central domain (green), and lysine- and glutamine residues involved in transglutaminase 
cross-linking (red) are indicated. Note: the specified amino acids involved in the transglutaminase 
mediated crosslinking reaction in SPRR4 were predicted based on sequence homology. Secondary 
structure prediction of the highly homologous SPRR proteins is indicated below the protein sequences. 
-Turn sequences predicted in all SPRR proteins are indicated by zigzag structures and the two -
helices in SPRR4 are also shown.  
 
Although loricrin is one of the major proteinaceous CE components, it appeared that 
its presence is not essential for the formation of the epidermal barrier. Knockout studies in 
mice revealed the existence of compensatory mechanisms in order to preserve barrier 
formation. In fact, loricrin-/- mice only show a delay (of a few days) in barrier formation but 
no major impairment of the barrier function79,93. To maintain the skin’s barrier function in 
these mice specific CE components are upregulated, such as the SPRR family members 
SPRR2D and SPRR2H as well as the fused gene member repetin93. Due to the increase of 
these CE proteins the absence of one major CE protein was compensated and normal 
cornified cell envelopes could still be assembled79. A similar mechanism will likely occur when 
one (or more) SPRR proteins are absent. Overall, these experiments highlight the extreme 
adaptability of the skin’s barrier function. 
As mentioned above, the different SPRR family members are highly similar in protein 
sequence. However, all individual SPRR proteins show specific expression patterns within 
various cornifying epithelia69,76,80,85,102,170,174. They were originally identified as UV-inducible 
genes and were found to be differentially affected during ageing, skin diseases, cancer, or in 




(e.g. retinoic acid or TPA treatment)2,17,29,58,59,61,74,75,81,82,86,96,110,120,160,185,203,204. Promoter 
region analysis revealed the existence of a great diversity in regulatory elements for the 
different family members. They all contain a dedicated mixture of AP-1, Ets, ATF, ISRE, 
octamer, and/or zinc finger transcription factor binding sites16,18,50-52,136,159. This versatility in 
regulatory elements explains the observed divergent gene expression. In this way, the SPRR 
proteins can be rapidly produced due to existence of multiple genes and a high flexibility in 
the overall protein dosage is allowed18. 
 
Global SPRR expression 
Ten years ago, SPRR expression was unexpectedly detected in non-squamous 
epithelia. Hooper and co-workers analysed the host response of the intestine to 
microorganism colonisation at a transcriptional level73. By using DNA microarrays they 
compared the gene expression profile of the intestine of germ-free mice with intestines 
colonised by various members of the microflora. The most pronounced response was the 
increase in SPRR2A by more than 200 fold while all other observed genes were only affected 
up to 10 fold73. This response, however, was specific for certain members of the microflora. 
The identified genes revealed that the combination of microorganisms in our microflora can 
affect important intestinal functions such as metabolism, nutrient absorption and 
angiogenesis73. At the same time, analysis of the adaptive response of the remaining 
intestinal tissue after small bowel resection revealed again the highest expressional change 
for SPRR2A177. 
Table 2: Upregulation of SPRR proteins identified in non-squamous epithelia 
Study SPRR Organ Organism Upregulated due to 
Ding36 SPRR1A Circulatory system mice Dilated cardiomyopathy 
Pradervand140 SPRR1A,2A,2B Circulatory system mice Ischemic stress 
Pyle143 SPRR3 Circulatory system human & mice Cyclic mechanical strain 
Pyle144 SPRR3 Circulatory system human 
Cyclic biomechanical 
stress 
Young206 SPRR1A,1B,2J,3 Circulatory system human & mice Atherosclerotic plaques 
Abgueguen1 SPRR2A Digestive system mice Iron overload 
Bracken14 SPRR3 Digestive system human Inflammatory disorder 
Demetris32 SPRR2A Digestive system mice Bile duct ligation 
Demetris33 SPRR2A Digestive system mice Biliary barrier defects 
Demetris34 SPRR2A Digestive system mice Bile duct ligation 
Hooper73 SPRR2A Digestive system mice Microflora colonisation 
Knight92 SPRR2A Digestive system mice Nematode infection 
Mueller129 SPRR2A Digestive system mice Helicobacter infection 
Nozaki133 
SPRR2A,2B,2E,
2I Digestive system human & mice Bile duct ligation 
Park135 SPRR2A Digestive system mice Embryonic development 
Ren146 SPRR2A Digestive system mice Electromagnetic pulses 
Stern177 SPRR2A Digestive system mice Small bowel resection 




Study SPRR Organ Organism Upregulated due to 
Sun181 SPRR2A Digestive system mice Bacterial infection 
Chen23 SPRR1B Eye human & mice Sjögren syndrome 
Chen24 SPRR1B,2A Eye human Osmotic stress 
De Paiva30 SPRR2 Eye mice Desiccating stress 
De Paiva31 SPRR2 Eye mice Desiccating stress 
Kawasaki88 SPRR2A Eye human Sjögren syndrome 
Li106 SPRR1B Eye human & mice Dry eye disease 
Tong188 SPRR1A,1B,3 Eye human Pterygium 
Gotter63 SPRR1B Lymphoid system human Thymic expression 
Bonilla13 SPRR1A Nervous system mice 
Peripheral axonal 
damage 
Carmichael21 SPRR1 Nervous system rat Stroke 
Fischer49 SPRR1 Nervous system rat Optic nerve injury 
Li107 SPRR1A Nervous system mice Spinal cord injury 
Lobsiger108 SPRR1A Nervous system mice 
Amyotrophic lateral 
sclerosis 
Marklund114 SPRR1A Nervous system rat Traumatic brain injury 
Starkey171 SPRR1A Nervous system mice Peripheral nerve injury 
Hong71 SPRR2A,2H Reproductive system mice Estrogen treatment 
Hong72 
SPRR2A,2B,2C,
2D,2E,2F,2G Reproductive system mice Estrogen treatment 
Kouros-Mehr99 SPRR1A Reproductive system mice 
Mammary branching 
morphogenesis 
Mercier124 SPRR1A Reproductive system mice Estrogen treatment 
Moggs127 
SPRR1A,2A,2C,
2E,2F,2G,2I,2J Reproductive system mice Estrogen treatment 
Morris128 SPRR1A,2A,2B Reproductive system mice 
Mammary gland 
development 
Robertson150 SPRR2A Reproductive system mice Prostate development 
Tan182 SPRR2A,2I Reproductive system mice Oestrous cycle 
Tan183 
SPRR2A,2B,2D,
2E,2F,2G,2K Reproductive system mice Oestrous cycle 
Tesfaigzi184 SPRR1 Reproductive system hamster Cell division 
Domachowske37 SPRR1A Respiratory system mice Viral infection 
Rouse152 SPRR2A Respiratory system mice 
Tobacco smoke and 
Ovalbumin 
Sandler157 SPRR Respiratory system mice Parasite eggs 
Vos195 SPRR1A,1B,2A Respiratory system human 
Pro-inflammatory 
cytokines 
Yoneda205 SPRR1B Respiratory system human 
Smoke and Hydrogen 
peroxide 
Zheng210 SPRR1A Respiratory system mice Carbon monoxide 
Zimmermann211 SPRR2A,2B Respiratory system mice Different allergens 
Chen22 SPRR2F,2I Urinary system mice Kidney stone diseases 
Saban156 SPRR2G Urinary system mice 
Bacillus calmette-guerin 
treatment 




Since then, SPRR expression appeared in all major tissues and cell types, mainly after 
stress or injury (Table 2). For example, in the lungs SPRR2A and SPRR2B were significantly 
increased by different allergens in asthmatic mouse models211. Also treatments with other 
stressors resulted in similar expression changes in the lungs. Exposure to tobacco smoke as 
well as injury induced by reactive oxygen species (ROS) in the form of hydrogen peroxide 
induces SPRR1B along with genes known to be involved in the reduction of oxidative 
stress205. ROS are also generated following ischemia-reperfusion regimens and result in 
tissue damage of the heart. Pradervand and co-workers identified massive induction of 
SPRR1A and SPRR2A after ischemic stress leading to the protection of cardiomyocytes140. 
Protection of the liver against bile, one of the most toxic biological fluids, is provided by the 
epithelial cells in the biliary tree. Disruption of this barrier by bile duct ligation resulted in a 
dramatic increase of SPRR proteins and subsequent adaptation of the biliary barrier133. In the 
uterus, SPRR2A was observed as the most upregulated gene during specific stages of the 
oestrous cycle182. During the pro-oestrous and oestrous stages SPRR proteins were highly 
induced, while at the metoestrous and dioestrus stages they were suppressed again182. 
Diverse SPRR proteins were also highly expressed during the development of the prostate 
gland150 and the mammary gland128.  
SPRR expression has also been identified in response to neuronal damage13. SPRR1A, 
which was undetectable in uninjured neurons, was the highest induced protein after 
peripheral axonal damage and was subsequently localised specifically to the injured axons. 
The axonal outgrowth of these damaged neurons seems to rely on the presence of SPRR 
proteins, since outgrowth was restricted after downregulation of SPRR1A by siRNA13. In 
addition to tissue damage, stroke induces sequential waves of neuronal growth-promoting 
genes to activate the process of axonal sprouting. By using microarray at different time-
points after stroke, SPRR1 was identified as a novel early responsive gene in peri-infarct 
cortex regulating the axonal sprouting process21. Overall, these expression profiles mainly 
show upregulation of SPRR in response to a variety of stressors or during the regeneration 
process after tissue-injury. 
 
ROS regulated wound healing 
All wounds, arisen by burning, scratching, myocardial infarction, or any other type of 
damage, heal in a similar fashion64. Following tissue-injury, the surrounding cells react 
rapidly to allow repair, avoid infections and protect against further loss of blood or tissue119. 
Due to their high accessibility cutaneous wounds are most studied. After disruption of the 
skin’s barrier, a dynamic multistep process of wound healing is activated involving the 
collaborative efforts of multiple celltypes117,168.  
As earliest danger signal a tissue-scale gradient of ROS (H2O2) is produced to attract 
leukocytes131. On top, these produced ROS directly protect the wounded tissue as chemical 
steriliser against invading microorganisms118. Meanwhile, haemostasis is achieved to prevent 
further blood and fluid loss and a fibrin clot is created as scaffold for the newly formed 
tissue64,168. At a transcriptional level many early response genes are produced to modulate 




of effector genes. The activity of some early response genes (e.g. Nrf2, NF-B, and AP-1) 
has been shown to be directly regulated by the amount of ROS present201,202. Since the 
wounded area is still highly oxidised it requires detoxification in order to allow migration and 
proliferation of the surrounding cells9. Subsequent induction of around 200 effector genes 
has been described at this stage of the wound healing process. The function of these genes 
ranges from direct antioxidants to extracellular matrix proteins and tissue remodellers27. The 
above described processes all happen within a few hours after wounding.  
 
Figure 4: Different stages of cutaneous wound healing. A, During stage one (inflammation), reactive 
oxygen species (ROS) are generated as chemical steriliser against invading bacteria and as signalling 
molecules to attract leukocytes. B, During stage two (new tissue formation), keratinocytes migrate 
into the wounded area to close the gap. C, During stage three (tissue remodelling), wound re-
epithelialization is completed and all injury activated processes are terminated. As a result a scar is 




During the second stage of wound healing, basal and suprabasal keratinocytes from 
the innermost epidermal layer start to migrate over the injured dermis64. Mechanistically, 
these migrating keratinocytes are very similar to the collective cell migration during 
embryonic development and cancer metastasis55,119. These diverse migrating cells all show 
collective polarisation, contain almost identical cytoskeletal machineries and invade a new 
environment. However, during the well regulated processes of morphogenesis and 
regeneration, specific cytoprotective genes are expressed to serve as flexible barrier9,115. This 
barrier, at the leading edge of the migrating cells, provides protection to both the migrating 
keratinocytes themselves as well as the tissue behind. The basal keratinocytes following the 
actively migrating cells begin to proliferate to eventually restore the epidermal barrier64,168. 
In the following chapters the role of SPRR proteins in  global wound healing is 
elucidated and the effect of ROS on their protective function will be highlighted. During 
wound healing, SPRR proteins reduce the high levels of ROS via their cysteine residues. This 
activity is directly related to their ability to promote cell migration. Likely, SPRR proteins 
provide all tissues with an efficient, finely tuneable antioxidant barrier, specifically adapted to 
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Among the three major POU proteins expressed in human skin, Oct-1, Tst-1/Oct-6 
and Skn-1/Oct-11, only the latter induced SPRR2A, a marker of keratinocyte terminal 
differentiation. In this study, we have identified three Skn-1 isoforms, which encode proteins 
with various N-termini, generated by alternative promoter usage.  These isotypes showed 
distinct expression patterns in various skin samples, internal squamous epithelia and cultured 
human keratinocytes. Skn-1a and Skn-1d1 bound the SPRR2A octamer site with comparable 
affinity and functioned as transcriptional activators. Skn-1d2 did not affect SPRR2A 
expression. Skn-1a, the largest protein, functionally cooperated with Ese-1/Elf-3, an 
epithelial-specific transcription factor, previously implicated in SPRR2A induction. This 
cooperativity, which depended on an N-terminal pointed-like domain in Skn-1a, was not 
found for Skn-1d1. Actually, Skn-1d1 counteracted the cooperativity between Skn-1a and 
Ese-1. Apparently, the human Skn-1 locus encodes multifunctional protein isotypes, 
subjected to biochemical cross-talk, which are likely to play a major role in the fine-tuning of 
keratinocyte terminal differentiation. 





The epidermis constitutes the interface between the organism and the environment 
and provides protection against physical, chemical and microbial damage. The major 
epidermal cell type, the keratinocyte, engages in a tightly regulated process of terminal 
differentiation, which is essential for the protective barrier of the skin and is reflected in vivo 
by the multi-layered structure of the epidermis. The innermost layer (stratum basale), 
connected to the dermis, comprises undifferentiated keratinocytes with a high proliferative 
potential. The cells committed to terminal differentiation migrate outwards into the non-
dividing suprabasal layers, and undergo distinct morphological and structural changes 
(reviewed in 70). The transition from proliferating basal keratinocytes to terminally 
differentiated cells is accompanied by a significant alteration in the gene expression 
program. The repression of genes required for cellular growth contrasts with the induction of 
genes related to cell-death and cornification. Aberrations in this tightly choreographed 
process will affect the expression of epidermal structural proteins, such as those involved in 
the formation of cytoskeleton, desmosomes and cornified cell envelopes. As a matter of fact 
many genetic and acquired human dermatoses have been linked to mutations or aberrant 
expression of these proteins29,141. 
Whereas the importance of structural proteins in safeguarding the integrity of 
epidermis and internal squamous epithelia is becoming well understood, little is yet known 
about the regulatory processes that are involved. Although ubiquitous transcription factors 
contribute to keratinocyte-specific gene expression38,52,56,78, the complex balance between 
proliferation, stratification and cornification is likely to be coordinated by cell type-specific 
proteins. Good candidates for such a function are the POU domain transcription factors, a 
family of more than 40 homeodomain-containing proteins involved in cell differentiation and 
tissue specification155,199. The characteristic POU domain consists of 2 conserved regions, a 
POU-specific domain and a POU homeodomain, connected by a hypervariable linker region. 
The entire POU domain is required for DNA binding. The octamer 5’-ATGCAAAT-3’ is the 
most frequent target for POU domain proteins200.  
Major POU domain factors in skin are Oct-1, Tst-1/Oct-6 and Skn-1/Oct-114. The ubiquitous 
Oct-1 is expressed in both proliferating and differentiating epidermal keratinocytes, whereas 
Oct-6 and Skn-1 are primarily expressed in suprabasal layers. Skn-1 is selectively expressed 
in the epidermis6,7,62,207. In vivo ablation of murine Skn-1 did not reveal a specific function for 
this gene, mainly due to redundancy with Oct-67. Recently, however, the use of in vitro raft 
cultures, disclosed a regulatory role of Skn-1 in keratinocyte proliferation and 
differentiation67.  
A further degree of regulatory complexity is due to the fact that at least several POU 
genes give rise to various isoforms, with specific functional properties and expression 
patterns (e.g. Oct-1, Oct-2, Brn-3 and Pit-1)155. Also the rat Skn-1 gene was shown to 
generate two functionally distinct transcripts, Skn-1a and Skn-1i 6. Here we show that the 
human homologue expresses three isoforms that differentially affected the expression of the 




whose regulation has been extensively studied52,109. This isotype-specific selectivity in 
SPRR2A regulation, which varied from activation to repression, depended on the differential 





Screening of a keratinocyte cDNA library 
A human keratinocyte cDNA library, constructed in Lambda ZAP II (Stratagene)113, 
was screened with probes from the POU domains of Oct-1 and Oct-225,178 at a stringent 
hybridization temperature. This yielded among others two independent Skn-1 clones. 
Plasmid DNA was isolated by in vivo excision with Exassist M13 helper phage (Stratagene).  
 
5’ rapid amplification of cDNA ends (RACE) 
5' RACE was performed on poly(A) RNA isolated from cultured normal human 
keratinocytes, essentially according to a previously described method42. Briefly, cDNA 
synthesized from 1 µg of poly(A) RNA, primed with a 5' biotinylated antisense oligonucleotide 
specific for Skn-1 (5’-biotin-GAAACCTCTTCTCCAGAGTCAGGCGG), was purified on Dynabeads 
coated with streptavidine (Dynal) and ligated to a 5' phosphorylated and 3' 3-amino-2-
propanol-ether blocked RACE-anchor (5’-phosphate-GCGGCCGCGTCGTGACTGGGAA 
AACCCOCH2CHOHCH2NH2). PCR, primed with various reverse Skn-1 primers (1: 5’-
ACCAAATACTTCACTGAGGCTGGGGTAGGAG; 2: 5’-AACCGCCGCAGCCCCACATCTCCCT GT; 3: 
5’-GAGGAGACCGCTTTGTTGCTGTGGA; position in GenBankTM accession number AF133895: 
814, 631 and 394 respectively) and a RACE-primer complementary to the anchor (5’-
GGGTTTTCCCAGTCACGACGCGGC), was performed with a 2.5:1 mixture of Pwo polymerase 
(Roche Applied Science) and Taq polymerase (HT Biotechnology Ltd.) for 40 cycles (20” 
94°C, 30” 50-60°C, 2’ 72°C). Fragments were cloned in pBluescript II SK(-) (Stratagene). 
 
Inverse PCR 
Genomic DNA was isolated from either simian COS-1 cells or mouse 3T3 fibroblasts 
by proteinase K digestion and phenol extraction. One µg of DNA was digested with either 
BstYI or Sau3AI and ligated with T4 DNA ligase (Amersham Biosciences). Ligated DNA was 
used in a PCR reaction with primers designed to contain restriction sites at the 5' end to 
facilitate subsequent cloning (simian sense primer: 5’-CGAATTCCCACAGACTGG GCCGGGACT; 
mouse sense primer: 5’-AGAATTCCCACAGACAGGGCCTGGCCT derived from the mouse cDNA 
sequence (GenBankTM accession number Z18537); common antisense primer: 5’-
AGAAAGCTTTGTTGCTGTGGAAAGG). 
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Semi-quantitative RT-PCR and RNA blotting 
Trizol reagent (Invitrogen) was used to isolate total epidermal RNA from tissue 
obtained either after breast reduction or circumcision. Total RNA (200 ng) was reverse 
transcribed with Super-RT (SphaeroQ) and random hexamers (Amersham Biosciences). 
Semi-quantitative PCR was performed according to a previously published procedure18 but 
using AmpliTaq Gold (Roche). The following isotype-specifc Skn-1 primers were used: Skn-
1a: sense: 5’-CACAGATATCAAGATGAGTG, antisense: 5’-TCTGAGATAGCAGGAACTG; Skn-1d1: 
sense: 5’-GTTGTAGCACATGTGTTTCA, antisense: 5’-GAAACCTCTTCTCCAGAGTCAG; Skn-1d2: 
sense: 5’-TCACCTTAGAGGGAGGAGA, antisense: 5’-CAGCCGGGAGTTGTAGAC. This analysis 
resulted in products of 330, 581 and 590 basepairs for Skn-1a, Skn-1d1 and Skn-1d2, 
respectively. Other primers were: SPRR2A: sense: 5’-TGGTACCTGAGCATCGATCTGCC, 
antisense: 5’-CCAAATATCCTTATCCTTTCTTGG18; Ese-1: sense: 5’-
CTGAGCAAAGAGTACTGGGACTGTC; antisense: 5’-CCATAGTTGGGCCACAGCCTCGGAGC. RT-
PCR conditions for GAPDH were described previously17. All primers bridged introns, thus 
allowing a control for DNA contamination. PCR products for the various Skn-1 isoforms were 
analyzed on a blot with a probe covering most of the cDNA (generated with the Skn-1a 
sense and the Skn-1d2 antisense primers). Sequence analysis was used to verify the identity 
of the various PCR products obtained. SPRR2A RT-PCR products were identified with an 
SPRR2 cDNA probe60. Ese-1 and GAPDH products were detected by ethidium bromide 
staining. RNA dot-blots were probed with a 511 bp KpnI/EcoRV fragment (3’ UTR) of Skn-1 
(GenBankTM accession number AF133895). 
 
In situ hybridization 
Experiments were carried out as described previously17. Digoxigenin-labeled (Roche 
Applied Science) sense and antisense RNA probes were generated using the 511 bp 
KpnI/EcoRV fragment (3’ UTR) of Skn-1 described above, a 680 bp fragment of SPRR269 and 
475 bp XhoI/BglII fragment (3’UTR) of Ese-1 (GenBankTM accession number U73844). 
 
Expression plasmids 
Protein expression plasmids were constructed by introducing the Skn-1 coding 
sequences in the HindIII and EcoRI sites of the T7 expression plasmid pT7-2. Plasmids 
encoding the whole open reading frame were generated for Skn-1a (pPOU117, from exon 1-
13), Skn-1d1 (pPOU123, from codon A in intron 5 to exon 13) and Skn-1d2 (pPOU121, exon 
8-13). For Skn-1d1, 3 mutants were constructed either by site-directed mutagenesis (point 
mutations in pPOU124 and pPOU118) or by PCR (pPOU137). Proteins encoded by these 
plasmids were synthesized in a coupled in vitro transcription-translation system (TnT 
reticulocyte lysate, Promega) in the presence of 35S-methionine (Amersham). Full-length Ets-
2, Ese-1, and Oct-2 cDNAs were isolated by screening the above mentioned human 
keratinocyte cDNA library either with Ets-specific159 or Oct-1/2 POU domain probes. For 
transfection the different cDNAs were cloned into the RSV-H20 expression plasmid158. 
Expression plasmids for Oct-1 and Oct-6 were gifts of Dr. W. Herr (Cold Spring Harbor) and 




Electrophoretic mobility shift assay 
Electrophoretic mobility shift assays were performed as described in Fischer et al 52. 
The SPRR2A octamer oligonucleotide (GGATAAATTTGCATCTGGCT) was labeled with T4 
polynucleotide kinase, purified by denaturing gel electrophoresis and reverse-phase 
chromatography, and subsequently annealed to the unlabeled complementary strand. In 
each reaction 2 l of programmed reticulocyte lysate and 20 fmol of labeled oligonucleotide 
duplex were used. 
 
Cell culture, transient transfections, CAT and luciferase assays. 
HaCaT cells were grown in DMEM with 10% bovine calf serum (Hyclone). Confluent 
cultures were transfected by incubating 5 cm culture dishes for 2 h with 5 µg of reporter 
plasmid (CAT or luciferase), 2.0 µg of Rous sarcoma virus expression plasmids (including 
compensating amounts of empty Rous sarcoma virus vector) and 40 µg of N-[1-(2,3-
dioleoyloxy)propyl]-N,N,N-trimethylammonium salts transfection reagent. Monolayers were 
washed with PBS and incubated for 24 h in culture medium. CAT assays were performed as 
described52. Luciferase activity was measured with the Luciferase Assay System (Promega) 
essentially as previously described158. All transfections were performed at least in triplicate. 
The SPRR2A minimal promoter-driven CAT plasmid pSG55 has been previously described52. 
Luciferase plasmids were constructed in pGL3 (Promega) and contained the following 
SPRR2A promoter inserts all derived from previously described plasmids52: pSG350-wt 






Structural characterization and organization of Skn-1 isoforms 
Searching the human genome database at NCBI with the previously described human 
Skn-1a cDNA (GenBankTM accession number AF133895) disclosed one sequence (GenBankTM 
accession number AP001150), encompassing the complete human gene. The 2868 bp cDNA 
sequence comprises 13 exons and extends over a 70-kilobase genomic region (Fig. 1A). The 
characteristic POU domain is encoded by exons 7-10. 
The screening of a human keratinocyte cDNA library with a POU domain probe and 5' 
RACE (see Experimental Procedures) identified 3 Skn-1 isoforms, namely the previously 
described Skn-1a66 and two novel variants, Skn-1d1 and Skn-1d2. Comparison with the 
genomic sequence revealed that the 5’ end of Skn-1d1 and Skn-1d2 corresponded to 
sequences in introns 5 and 7, respectively (Fig. 1A). The absence of other introns in these 
transcripts confirmed the mRNA origin of both clones. 





Fig. 1. A, Genomic organization of the human Skn-1 gene. The transcription start sites for Skn-1a, 
Skn-1d1 and Skn-1d2 are indicated by arrows. The POU-specific domain (POU-S) and the POU-
homeodomain (POU-HD) of Skn-1a are represented. Exons are boxed and introns are numbered. kb, 
kilobases B, Part of human intron 5 is compared with the corresponding sequence from simian, rat 
(GenBankTM accession number L23863) and mouse. Simian and murine sequences were obtained 
from inverse-PCR on Cos-1 and 3T3 cells respectively (“Experimental Procedures”). An asterisk 
indicates the start of the longest 5’ RACE clone for Skn-1d1. Bases shown in lower case correspond to 
intronic sequences; various initiation and termination codons that are discussed in “Results”, and the 
3’ splice-site of intron 5 are highlighted. C, Sequence of the longest 5’ RACE clone for Skn-1d2. 
Potential initiation and termination codons are indicated. Intron sequences are shown in lower case. 
The sequence of exon 8 is underlined. The 3’ splice site is represented in bold.  
 
The human Skn-1d1 transcript is homologous to the Skn-1i variant of rat6 and is 
compared in Fig. 1B with the corresponding simian and rodent sequences. The translation 
initiation codon previously identified in the rat (codon 1) is not present in the human 
sequence. Both primate genes contain an AUG codon (codon A), which is in frame with the 
Skn-1a coding sequence. However, this start codon is not likely to be functional since it is 
followed by a termination codon UAG (codon B), that is not present in rodents. A putative 
low-affinity initiation codon CUG for Skn-1d1 is found at position 85 in the beginning of exon 




The sequence of the Skn-1d2 transcript, which initiates in intron 7, revealed 3 intron-
encoded AUG codons, in frame with the POU domain sequence, but followed by a 
termination codon at position 154 (Fig. 1C). Potential start codons for open reading frames 
are found in exon 8 (codon D and/or codon E).  
 
DNA binding activity of the hSkn-1 variants 
The integrity of the Skn-1 expression plasmids and their coding potential were 
verified by producing proteins in vitro with the TNT reticulocyte lysate system (Promega) 
(Fig. 2B). Skn-1a (pPOU-117) migrated at the predicted molecular mass (47.5 kDa) and 
bound to the SPRR2A octamer site (Fig. 2C). The Skn-1d2 isoform (pPOU-121) generated 
two different products (Fig. 2B). The slow migrating product has an apparent molecular 
mass of 25 kDa, which is in accordance with a protein initiating at codon D in the POU-
specific domain (Fig. 1C). The 21.5 kDa product corresponds to a protein starting at initiation 
codon E. None of these Skn-1d2 isoforms is capable of binding to the SPRR2A octamer site 
(Fig. 2C), which is likely due to the partial deletion of the POU-specific domain (Fig. 1A). 
The wild type Skn-1d1 transcript (plasmid pPOU-123) codes for a major polypeptide 
of 35 kDa, and two minor products of 33 and 31 kDa (Fig. 2B). To investigate translational 
initiation of Skn-1d1 proteins more precisely, constructs with mutations in codons A, B or C 
(Fig. 1B and 2A) were generated. Fig. 2B shows that translation of the major Skn-1d1 
polypeptide most likely initiates at codon C (a weak CUG initiation codon). Indeed, pPOU-
137, in which this codon was changed into an efficient AUG initiator, yielded high levels of a 
product of 35 kDa, identical to the largest polypeptide from the wild type transcript. This 
cDNA was used in  transfection experiments. The minor 33 and 31 kDa proteins were not 
investigated further. 
Electrophoretic mobility shift assays were performed to compare the binding affinity 
of Skn-1a (pPOU-117) and Skn-1d1 (pPOU-137) to the SPRR2A octamer site. Labeled 
double-stranded SPRR2A octamer oligonucleotide was incubated with reticulocyte lysate 
programmed with either Skn-1a or Skn-1d1. As shown in Fig. 2D, competition with 
increasing amounts of unlabeled binding site revealed that both Skn-1 variants bound the 
SPRR2A octamer site with similar affinities. 
 
Transactivation potential of Skn-1 isoforms 
In Fig. 3A, the SPRR2A proximal promoter, fused to the CAT reporter and 
encompassing all cis-elements necessary for expression during keratinocyte terminal 
differentiation52, was transiently transfected into HaCaT cells, which contain low levels of 
endogenous POU proteins67. We first evaluated the transactivation potential of Oct-1, Oct-
6/Tst-1 and Skn-1a, the major POU domain proteins expressed in skin4, and of Oct-2, a 
lymphoid specific transcription factor25, also expressed in cultured human keratinocytes7 (our 
unpublished observation). Oct-1 and Oct-2 did not affect baseline expression of SPRR2A, 
Oct-6 repressed promoter activity by ~70% and Skn-1a was the only POU domain protein 
tested that mediated gene activation (3-4 fold induction, Fig. 3A). 




Fig. 2. DNA binding activity of in vitro synthesized Skn-1 isotypes. A, Plasmids used for in vitro 
transcription-translation. The various mutations in Skn-1d1 are indicated. Nomenclature of codons A, 
B and C is according to Fig. 1B. B, SDS-PAGE analysis of in vitro synthesized Skn-1 proteins. 
Reticulocyte lysates were programmed with the indicated Skn-1 plasmid or with a control plasmid 
(pT7-2, lane 1). Molecular weight markers (Amersham Biosciences) are indicated in the margin (in 
kDa). Skn-1d1 and Skn-1d2 specific products are marked with asterisks. C, Electrophoretic mobility 
shift assay of Skn-1 programmed lysates (lanes 1-6), or un-programmed lysate (lane 7) with the 
SPRR2A octamer site. D, Affinity of Skn-1a or Skn-1d1 for octamer binding: reticulocyte lysate 
containing identical amounts of either Skn-1a or Skn-1d1 protein were incubated with 20 fmol of the 





To investigate the relative contribution of the individual Skn-1 isoforms in the 
regulation of the SPRR2A gene, the transactivation potential of the three variants was 
determined by transfecting increasing amounts of isotype-specific expression plasmids into 
HaCaT cells, programmed with an SPRR2A-luciferase construct. Both Skn-1a and Skn-1d1 
up-regulated the SPRR2A promoter by 3-4 fold. The saturation kinetics were, however, 
different because lower amounts of Skn-1a were needed to reach a plateau, indicating that 
Skn-1a can transactivate the SPRR2A promoter more efficiently than Skn-1d1 (Fig. 3B). Skn-
1d2 had no effect on SPRR2A promoter activity, even at higher doses. Collectively, these 
results indicate that among several POU domain proteins only Skn-1a and Skn-1d1 are able 
to activate the SPRR2A promoter in an in vitro transient transfection experiment. Hence, it 
was important to investigate whether a similar direct relation existed also in vivo between 
Skn-1a/d1 and SPRR2A expression. 
 
Fig. 3. Effect of various POU 
proteins on SPRR2A 
promoter activity. A, The 
SPRR2A-CAT reporter 
construct (pSG55) was 
either transfected alone or 
together with expression 
plasmids for Oct-1, Oct-2, 
Oct-6 and Skn-1a into 
HaCaT keratinocytes as 
described under 
“Experimental Procedures”. 
CAT activity was determined 
24 h after transfection as 
previously described52 and 
was related to the basal 
activity of pSG55. B, 
Increasing amounts of Skn-
1a, Skn-1d1 and Skn-1d2 
expression plasmids were 
co-transfected with the 
SPRR2A-luciferase reporter 
construct (pSG350) and 
luciferase activity was 
determined 24 h later 
essentially as previously 
described158. 
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Correlation between SPRR2A and Skn-1a expression in vivo. 
Initially, a panel of 50 different RNA samples from various human tissues was 
analyzed with a Skn-1 specific probe (3’ UTR) which detects all isoforms. Skn-1 expression 
was restricted to a few stratified squamous epithelia including epidermis, cervix and foreskin 
(results not shown). To compare the expression pattern of the 3 human Skn-1 variants with 
SPRR2A expression, semi-quantitative RT-PCR with isotype-specific primer sets was 
performed on RNA isolated from either total skin, epidermis, foreskin, cervix or cultured 
primary keratinocytes. RNA from uterus, which does not contain SPRR2A transcripts18, was 
used as a negative control. The results in Fig. 4A show that Skn-1a was expressed in all 
squamous epithelia (lanes 1-6 and 8) and in cultured keratinocytes (lane 7), although at 
different levels. Expression of Skn-1d1 was more heterogenous, as it was not detected in the 
skin and cervix samples from lanes 1 and 8, respectively. Relatively high expression levels of 
Skn-1d1 (already visible after 25 cycles) were found in the epidermal RNAs from lanes 2, 3 
and 5. Skn-1d2 expression was, in general, similar to the one of Skn-1a. The absence of 
Skn-1 transcripts in uterus correlated well with the absence of SPRR2A expression. However, 
no clear correlation was found in the other samples between the expression level of one of 
the Skn-1 isotypes and SPRR2A expression, indicating the involvement of other transcription 
factors. Indeed, previous work from our laboratory has shown that expression of SPRR2A 
relied on interdependent regulatory promoter elements, recognized by various classes of 
transcription factors52. Consequently, we have also monitored the expression of the epithelial 
specific Ets factor Ese-1, previously implicated in SPRR regulation134,159. Expression of this 
gene was found in all samples, including uterus (although at low levels). The highest levels 
were found in the epidermal sample of lane 2, in cultured keratinocytes (lane 7) and in 
cervix (lane 8). Again, no strict correlation was found between the levels of Ese-1 and 
SPRR2A expression (Fig. 4A). 
To investigate whether Skn-1 and Ese-1 co-localize in vivo, we monitored the 
stratum-specific expression of Skn-1, Ese-1 and SPRR2A in sections of foreskin (Fig. 4B). 
Whereas Skn-1 (the 3’ UTR probe used detects all isoforms) was present in most suprabasal 
layers, Ese-1 expression was confined to the more differentiated layers. Most importantly, 
the distribution of both factors overlapped with the expression of SPRR2A. Because both 
octamer and Ets binding sites in the promoter are essential for SPRR2A expression52, we 
questioned whether Skn-1 isoforms and Ese-1 had the potential to cooperate in SPRR2A 
transactivation. 
 
Ese-1 selectively cooperates with Skn-1a in the transactivation of the SPRR2A 
promoter. 
HaCat cells were transfected with the SPRR2A-luciferase reporter construct (PSG350) 
together with increasing amounts of the different transcription factors, either alone or in 
various combinations (Fig. 5). The total amount of transfected expression plasmid was kept 
constant by compensating with the empty vector. Skn-1a, Skn-1d1 and Ese-1 alone induced 
the SPRR2A promoter 3 to 4 fold at saturation. However, cotransfections of Skn-1a and Ese-
1 activated the same promoter in a dose dependent manner up to 8 fold, suggesting 





Fig. 4. A, Semi-quantitative RT-PCR analysis of Skn-1, Ese-1, SPRR2A and GAPDH expression in 
various human tissues and cells. RNA isolated from total skin (lane 1), isolated epidermis (lanes 2-5), 
foreskin (lane 6), cultured primary keratinocytes (lane 7), cervix (lane 8) and uterus (lane 9) were 
analyzed with SPRR2A, Ese-1, GAPDH and isoform-specific Skn-1 primers. PCR was performed with 
25, 30 and 35 cycles and products were either detected with gene-specific probes (Skn-1 isoforms and 
SPRR2A) or by direct ethidium bromide staining (Ese-1 and GAPDH). For GAPDH only the 30 cycle 
product is shown. B, In situ hybridization performed with digoxigenin-labeled Skn-1, SPRR2 and Ese-1 
specific RNA probes. A foreskin section was analyzed with sense (a, c, e) and antisense (b, d, f) 
probes. Bar, 100 m. 
 
not found in combinations of Skn-1d1 with Ese-1 (Fig. 5B), nor with Skn-1a and Ets-2 (Fig. 
5C), another Ets transcription factor previously implicated in keratinocyte terminal 
differentiation103. Apparently, only Skn-1a can specifically cooperate with Ese-1 in the 
activation of the SPRR2A gene. 
Figure 5D shows the effect of Skn-1d1, Skn-1d2 or Ets-2 on the cooperative 
activation of the SPRR2A promoter by Skn-1a and Ese-1. Although neither Skn-1d2 nor Ets-2 
was able to affect the cooperativity between Skn-1a and Ese-1, a clear drop in promoter 
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activity was observed when Skn-1d1 was included. Apparently Skn-1d1 is able to compete 
with Skn-1a for promoter binding even in the presence of Ese-1, resulting in a complete 
abrogation of the synergistic effect. In the case of Ets-2 the situation is different: Ets-2 can 
at least partially down-modulate the activity of Skn-1a in the absence of Ese-1 (Fig. 5C) but 
not in its presence (Fig. 5D). Furthermore it is shown that mutations in either Ets (PSG390) 
or octamer binding site (PSG527) resulted in a complete inhibition of SPRR2A promoter 
activity, in agreement with our previously published results52. 
Taken together, our results show that although both Skn-1a and Skn-1d1 could 
transactivate the SPRR2A promoter, only Skn-1a was able to functionally cooperate with Ese-
1, resulting in enhanced transactivation. Skn-1d1 was able to counteract this functional 
cooperativity. 
 
Fig. 5. Transcription factor cooperativity and antagonism during SPRR2A gene regulation: 
Cotransfection of the SPRR2A-luciferase reporter construct (5 g) with the indicated total amounts 
(g) of expression plasmids for Skn-1a and/or Ese-1 (A), Skn-1d1 and/or Ese-1 (B), Skn-1a and/or 
Ets-2 (C). When more than one transcription factor was transfected in the same mixture, the plasmids 
were always added in equal amounts. The total amount of transfected expression plasmid was kept 
constant at 2 g by compensating with empty vector. D, Cotransfection of the wild-type (pSG350) or 
mutant (octamer site: pSG527; Ets site: pSG390) SPRR2A promoter constructs with Skn-1a/Ese-1 and 
the indicated transcription factor expression plasmids. Transfection and luciferase measurements were 







In this study, we have identified and characterized three isoforms of the human Skn-
1/Oct-11 gene and assessed their ability to regulate the human SPRR2A gene. The promoter 
of this gene has been well characterized in the past and its activation during keratinocyte 
differentiation has been well documented. It encompasses an octamer binding site, that is 
recognized by Skn-1 and is essential for promoter activity together with three other 
transcriptional control elements, bound by respectively the Ets, Irf and Klf transcription factor 
families52. Among these, only the Ets binding activity has previously been identified as the 
epithelial-specific Ets factor, Ese-1134. Our previous finding, that destruction of a single 
binding site results in a complete loss of promoter activity, has stressed the importance of 
signal integration and transcription factor cooperativity in the regulation of this gene52. Here, 
we have used this well-documented facet of SPRR2A regulation, to analyze the regulatory 
abilities, including possible synergistic/antagonistic activities, of the three different Skn-1 
isoforms that we have identified. 
The human Skn-1 gene produces three mRNA species, encoding proteins with various 
N-termini (Fig. 6A). The two shorter mRNA variants are the result of internal promoter usage 
and initiate within introns 5 and 7. The observation, that the three transcripts are 
differentially expressed in various skin samples and in cultured human keratinocytes (Fig. 
4A), indicates that the corresponding promoters function independently and are subjected to 
selective regulation. Although the Skn-1d1 and Skn-1d2 variants originate within introns, 
termination codons prevent the addition of specific N-terminal (“intron” encoded) sequences 
to the proteins. Consequently, Skn-1d1 and Skn-1d2 can be viewed as N-terminal deletions 
of Skn-1a. 
Skn-1a, which encodes the full-length protein, is identical to the mRNA previously 
described by others66, and is highly homologous to its rat and mouse orthologues6,62. Skn-1a 
transcripts are expressed in all human skin samples analyzed (Fig. 4A). The higher level of 
expression in epidermal samples (lanes 2-5), as compared with a total skin preparation (lane 
1), correlates with the epidermal expression of this gene (Fig. 4B). Our analysis clearly 
shows that SPRR2A expression is not strictly linked with either Skn-1A or Ese-1 expression, 
but it clearly correlated with the presence of both factors. For instance, low levels of Ese-1 in 
uterus do not induce SPRR2A expression due to the absence of Skn-1a (Fig. 4A, lane 9). 
However, weak expression of Skn-1a can be compensated by the presence of Ese-1, and 
result in efficient SPRR2A expression in cultured keratinocytes and cervix (lanes 7-8). These 
in vivo expression data are in line with our transient transfection experiments, which have 
established cooperativity of Skn-1a and Ese-1 in SPRR2A promoter transactivation (Fig. 5) 
and corroborate the previously identified necessity for signal integration in the regulation of 
SPRR2A52. 
Skn-1d1 did not have the ability to synergize with Ese-1. Because Skn-1a and Skn-
1d1 exhibited comparable DNA-binding activities with the SPRR2A octamer site, the 
functional cooperativity between Skn-1a and Ese-1 is likely to be mediated by a specific 
domain in Skn-1a, which is not present in Skn-1d1. Hence, the 122 aminoacid N-terminal 
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part of Skn-1a, which is absent in Skn-1d1 (Fig. 6A), was screened for possible structural 
domains by using 3D-PSSM90, a fold recognition program at Imperial Cancer Research Fund 
(London) (http://www.sbg.bio.ic.ac.uk/3dpssm). This search has revealed between amino 
acids 35-121 a region with significant similarity to the canonical sterile  motif/pointed 
domain (Fig. 6B). This fold, which is found in many different proteins, including for instance 
the Ets and p53 transcription factor families, functions essentially as a protein-protein 
interaction interface8,105. It might seem tempting to speculate that the pointed-like domain 
(PLD) in Skn-1a interacts directly with the Ese-1 pointed domain. However, such an 
interaction would not account for the highly specific cooperativity between Skn-1a and Ese-1 
that we have observed. Ets-2 also contains a pointed domain; it has the ability to bind to the 
SPRR2A Ets site, but it does not synergize with Skn-1a. Consequently, it seems more likely 
that the Skn-1a pointed-like domain contacts a protein domain in Ese-1, which is specific for 
this factor. 
 
Fig. 6. A, Schematic representation of the various Skn1 isoforms identified in this study. The POU-
specific domain (POU-S), the POU-homeodomain (POU-HD) and the pointed-like domain (PLD) are 
represented. The amino acid numbering corresponds to the Skn-1a isoform. B, Comparison of the N-
terminal region (amino acids 35-121) of Skn-1a with the sterile  motif /pointed domains of Ets-1 and 
p73-. Identical and similar amino acid residues are highlighted in grey and the predicted -helices in 
Skn-1a (3D-PSSM) and those in the resolved structures of Ets-1169 and p73196 are boxed. As a 
reference -helices in Ets-1 are numbered H1-H5. 
 
The human Skn-1d1 mRNA is conserved among rodents and primates; however, its 
coding potential has clearly changed during evolution. Although in primates the region 
encoded by intron 5 is not translated (due to in-frame termination codons), it encodes in rat 
and mouse an N-terminal 32-amino acid domain (Fig. 6A) that is responsible for the 
inhibitory activity of the Skn-1i isoform6. Skn-1d1 did also inhibit SPRR2A promoter activity in 
the presence of Skn-1a and Ese-1 (Fig. 5D), although it had the ability to activate the same 




1d1 expression was inversely related to high SPRR2A expression. For instance in the 
epidermal samples of lanes 2, 3 and 5, where high expression of Ese-1, Skn-1a and Skn-1d1 
is monitored, expression of SPRR2A is clearly lower than in foreskin (lane 6), where high 
expression of Skn-1a and Ese-1 contrasts with low expression of Skn-1d1. Similarly, 
comparison of lanes 7 and 8 (cultured keratinocytes and cervix) reveals that similar levels of 
Skn-1a and Ese-1 lead to lower expression of SPRR2A in the cultured cells (lane 7) due to 
the presence of Skn-1d1. The mechanisms by which hSkn-1d1 and mSkn-1i inhibit gene 
expression differ, however, fundamentally. Whereas the mSkn-1i inhibitory domain acts in cis 
and inhibits DNA binding6, the human counterpart has the same DNA binding affinity as Skn-
1a. Due to this property it can compete with Skn-1a for octamer binding, and interfere in this 
way with the cooperative activation of SPRR2A by Skn-1a and Ese-1. The differential effect 
of Skn-1d1 on SPRR2A expression, in the presence or absence of Skn-1a/Ese-1, is also 
interesting from a different point of view. It might actually shed light on several unexplained 
findings, concerning the relative transactivation potential of Skn1a and various truncated 
constructs, including an N-terminal deletion66,180. In these experiments the outcome 
depended greatly on the specific promoter that was tested. Although the N-terminal deletion 
of Skn-1a induced K10 and HPV1a promoter activity, no discernible effect was observed on 
HPV-18, and K14 was inhibited. Our results suggest that such variable outcomes can be 
expected and that they are likely to depend mainly on the specific transcription factor 
occupancy of the promoter that is analyzed. This is especially true for promoters subjected 
to strict combinatorial gene regulation, such as SPRR2A52 and most likely also for the various 
promoters mentioned above. Consequently, to be able to fully appreciate the outcome of 
transcription factor truncation experiments, a reasonable knowledge of the regulatory 
configuration of the promoter, that is analyzed, is a prerequisite. A similar complexity has 
also recently been observed for the profilaggrin promoter and is discussed by the authors78. 
The human Skn-1d2 isoform codes for two proteins, lacking the first 27 or 53 
aminoacids of the POU-specific domain, whereas the POU-homeodomain is left intact (Fig. 
6A). It has previously been shown that both sub-domains are required for DNA binding91. 
This probably explains why Skn-1d2 neither bound to the SPRR2A octamer site nor affected 
promoter activity. However, Skn-1d2 was widely expressed, with transcripts detected in all 
skin samples analyzed. This feature suggests that Skn-1d2 might have a physiological role, 
which does not depend on DNA binding. Indeed, POU domain proteins have been shown to 
regulate transcription also through protein-protein contacts, in a DNA-binding independent 
manner. These interactions are often mediated by the POU-specific, the POU-homeo or both 
domains and target other transcription factors, co-regulators, basal factors and chromatin 
components (for a recent review, see Ref.5). For instance, downregulation of keratin 14 is 
mediated by the POU-domain of either Skn-1a or Oct-6, and does not involve DNA binding to 
the K14 promoter180. In the case of Oct-1, several protein-protein interactions are mediated 
solely via the POU homeodomain5. Consequently, it is possible that the Skn-1d2 encoded 
proteins, which still have intact POU homeodomains, have the ability to affect gene 
expression by similar protein-protein interactions. More experiments will be needed to 
unravel a possible regulatory function of the Skn-1d2 isoforms. 
Our work describes for the first time a functional interaction between the Skn-1a and 
Ese-1 transcription factors. The differential cross-talk of Skn-1a and Skn-1d1 with Ese-1 
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highlights the complexity of combinatorial gene regulation during keratinocyte terminal 
differentiation. The strict dosage of Skn-1 isoforms is likely to guarantee both the fine-tuning 
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Chapter III  
 
 
Skin cornification proteins provide global link 
between ROS detoxification and cell migration 




































Wilbert P. Vermeij and Claude Backendorf 



















Wound healing is a complex dynamic process characterised by a uniform flow of 
events in nearly all types of tissue damage, from a small skin scratch to myocardial 
infarction. Reactive oxygen species (ROS) are essential during the healing process at multiple 
stages, ranging from the initial signal that instigates the immune response, to the triggering 
of intracellular redox-dependent signalling pathways and the defence against invading 
bacteria. Excessive ROS in the wound milieu nevertheless impedes new tissue formation. 
Here we identify small proline-rich (SPRR) proteins as essential players in this latter process, 
as they directly link ROS detoxification with cell migration. A literature-based meta-analysis 
revealed their up-regulation in various forms of tissue injury, ranging from heart infarction 
and commensal-induced gut responses to nerve regeneration and burn injury. Apparently, 
SPRR proteins have a far more widespread role in wound healing and tissue remodelling 
than their established function in skin cornification. It is inferred that SPRR proteins provide 
injured tissue with an efficient, finely tuneable antioxidant barrier specifically adapted to the 
tissue involved and the damage inflicted. Their recognition as novel cell protective proteins 
combining ROS detoxification with cell migration will provide new venues to study and 
manage tissue repair and wound healing at a molecular level. 





Reactive oxygen species (ROS) are produced directly after tissue damage and are 
essential during various stages of the healing process, ranging from the initial signal that 
instigates the immune response to the defence against invading bacteria131,162. For efficient 
healing, the injured tissue has to rapidly adapt via ROS detoxification to allow correct 
regulation of redox-sensitive signalling pathways implicated in the healing process162,165,168. 
This rapid response is crucial in all tissues especially during injury, notably in the heart and 
brain140. Due to its accessibility, cutaneous wounding, where a temporal defect results in a 
local loss of the skin’s protective barrier function64,117, is particularly well studied. This 
barrier, which normally provides protection against external insults, is maintained, restored 
and continuously self-renewed by proliferating, migrating and terminally differentiating 
keratinocytes19,130. When basal keratinocytes initiate the differentiation process, they 
undergo morphological changes and express several cornified envelope precursor proteins, 
such as involucrin, loricrin, and the small proline-rich (SPRR) proteins, ending as a layer of 
dead flattened cells on the skin surface. In this upper cornified layer, the precursor proteins 
are cross-linked at the cell periphery and form together with lipids the cornified cell envelope 
(CE), a structure which is responsible for the major barrier function of the skin84,151. The 
SPRR gene family is part of the epidermal differentiation complex (EDC) localised on human 
chromosome 1q21 and mouse chromosome 3. Many of the genes in this locus are co-
ordinately regulated during epidermal differentiation. SPRRs are specifically known as stress-
inducible proteins involved in the adaptation of the skin barrier following various forms of 
stress18. During wound healing keratinocytes are the first cells to adapt to defects in the 
barrier and switch from a differentiating to a migratory mode in order to form new tissue54,64. 
Migrating keratinocytes lack the CE and therefore an alternative protective barrier appears 
crucial to enter the highly oxidised wound. 
Here we show that SPRR proteins protect keratinocytes from excessive ROS by direct 
quenching via their cysteine residues. This activity is directly related to their ability to 
promote cell migration. A literature-based meta-analysis disclosed that SPRR proteins do not 
only exert this function in squamous epithelia but also in a wide range of other major tissues 
and organs.  
 
 
Results and Discussion 
 
While analysing wounded three-dimensional human skin equivalents (HSE)43 we 
found that SPRR proteins showed massive expression at the migrating front (Figure 1A; 
arrows), which exceeds their normal expression in the upper layers of the skin (arrowheads). 




wounded site, suggesting a role in cell migration and new tissue formation. This was 
substantiated by using a scratch wound assay performed on cultured human keratinocytes. 
Immunofluorescence staining showed, similar to the HSE data, elevated SPRR expression at 
the edge of the wound, localising preferentially to the cell periphery of the front row of 
migrating cells (Figure 1B). This pattern is observed along the whole length of the scratch, 
although in a patchy fashion. Indeed, the most protruding migrating cells show the highest 
expression of SPRR at the cell periphery (Figure 1B).  
 
Figure 1. Involvement of SPRR proteins in wound healing and cell migration. A, 
Immunohistochemistry of SPRR1 expression (brown) in full-thickness wounds obtained after N2 
freezing43. Expression in the migrating front cells at the edge of the wound is indicated by large 
arrows. Differentiation-mediated expression in the upper layers of the epidermis is indicated by arrow-
heads. B, Immunofluorescence detection of SPRR1 expression (green) in cultured OKF keratinocytes 8 
h after scratch-wounding. Note the preferential localisation of SPRR1 at the periphery of the cells at 
the edge of the scratch-wound. C, SPRR Western blot analysis of control OKF and shRNA 
downregulated OKF-∆1 cells. Actin expression is used as internal control. D-G, Inhibition of cell 
migration in SPRR knockdown cells. OKF control (D, E) and OKF-∆1 knockdown cells (F, G) were 
compared in a scratch-wound assay. Pictures D, F, were taken immediately after scratch-wounding, 
whereas pictures E, G, were taken after a subsequent 48 h incubation period. 
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This localisation at the moving edge is also supported by live-cell-imaging of pEGFP-SPRR1B 
transfected keratinocytes, further accentuating the presence of SPRR in membrane ruffles at 
the migrating front of the cell (Movie S1). In order to find evidence for a direct link between 
SPRR expression and cell migration, we established keratinocyte cell lines expressing shRNA 
specifically targeting SPRR genes (OKF-∆1; see Material and Methods) or carrying the empty 
expression vector (OKF). Under normal culture conditions both cell lines were 
undistinguishable and showed similar population doublings (data not shown), although in the 
shRNA expressing cells (OKF-∆1), SPRR expression was clearly down-regulated (Figure 1C). 
When comparing the ability of wound closure, however, a remarkable difference was 
perceived between the control and shRNA expressing keratinocytes. Whereas control 
keratinocytes started to migrate after scratch-wounding (compare Figure 1D and 1E), 
resulting in a substantial closure after 48 hours, this process was significantly retarded in the 
SPRR down-regulated cells (Figure 1F and 1G). Quantification substantiated that the shRNA 
expressing cells lack the ability of rapidly closing the wound (Figure 2, compare the 2 lines 
with open symbols), indicating that SPRR expression after wounding activates the cell 
migration process.  
Figure 2. Effect of ascorbate on 
scratch-wound closure. Quantification 
of scratch closure at the indicated time-
points in confluent OKF control cultures 
(square symbols) or OKF-∆1 SPRR-
knockdown cells (circle symbols) either 
treated (solid symbols) or untreated (open 
symbols) with 10 μM ascorbate following 
scratch-wounding. Data show mean +/- 
s.e.m. of at least 6 independent 
measurements per time-point. Curves 
from treated and untreated cultures were 
analysed via two-way ANOVA by using the 
Graphpad Prism software: p < 0.05 values 
were considered to indicate a significant 
difference.  
 
By taking into account the previously postulated role of SPRR proteins as ROS 
quenchers3, their localisation in the moving front of migrating cells directly contacting the 
wounded area (Figure 1) and the importance of ROS regulation and signalling during wound 
healing28,131,162,165, we inferred that the antioxidant properties of SPRR proteins might 
constitute the key for their implication in cell migration and wound healing. Consequently, it 
was important to first characterise the ROS quenching abilities of SPRR proteins at a 
molecular level. Flash-photolysis was used to quantify the life-time of singlet oxygen, a major 
oxidizing species in skin94, either in solution in the presence of purified SPRR proteins or 
directly in living cells. SPRR proteins contain besides proline high amounts of cysteine (5-
18%; Figure 3A), known to be involved in ROS quenching125 and signalling28,165. As expected, 
SPRR1B efficiently quenched singlet oxygen and this quenching was largely inhibited by 




(Figure 3B, compare bars 1 & 2). Histidine residues in SPRR1B contributed also to ROS 
quenching, but to a lesser extent (DEPC treatment, bar 3). The quenching ability of the 
related SPRR4 protein17, which contains cysteine but no histidine residues, was not affected 
by DEPC, while treatment with NEM resulted in a loss of 96% of its quenching activity (see 
Figure S1). These experiments directly implicate cysteine residues in ROS quenching by 
SPRR proteins. Flash-photolysis was also used to measure ROS quenching in living cells. 
OKF-∆1 and OKF-∆2 cells, where SPRR expression is downregulated to a different extent 
(Figure 3C), were compared to OKF control cells carrying the empty expression vector. The 
data clearly showed that down-regulation of SPRR results in a lower quenching potential. 
Similarly, ectopic expression of SPRR1B in HeLa cells, which do not express SPRR proteins, 
resulted in a substantial potentiating of ROS quenching (Figure 3D). The fact that these 
differences could be measured in the context of whole cells proves that SPRR proteins 
constitute a key determinant for intracellular ROS quenching. The major cellular impact of 
ROS in living cells is mediated via the induction of DNA strand breaks. In a comet assay 26 
HeLa cells, ectopically expressing SPRR1B (Figure 3E, red curve), were significantly more 
resistant to H2O2 induced DNA breaks than HeLa control cells (black curve). These 
experiments suggest a direct and major involvement of SPRR proteins in intracellular ROS 
detoxification. To assess the importance of ROS detoxification during wound healing, the 
scratch-wounded OKF-∆1 cells were treated with ascorbate, a well known ROS quencher. 
The loss of migratory ability due to SPRR down-regulation (Figure 2, compare open circles 
and squares) can at least be partially reverted by ascorbate (solid circles). Interestingly, 
ascorbate did not affect the migratory properties of SPRR expressing control cells (compare 
open and solid squares). Apparently, the enhancement of cell migration is not a general 
effect of ascorbate, but it is only apparent in a SPRR-deficient background, proving that 
SPRR mediated ROS detoxification is directly responsible for efficient cell migration. 
In order to further validate these in vitro experiments by in vivo observations, we 
performed a meta-analysis on recent genomic/proteomic screens and were able to find 
evidence for up-regulation of SPRR expression during wound healing in the skin. Cooper and 
co-workers analysed gene-expression in wounded skin from neonatal mice at different time 
points by clustering genes with similar expression patterns. Although not specifically 
mentioned by the authors, the analysis revealed several SPRRs among the most highly up-
regulated genes, together with proteins with a known antioxidant function, all involved in 
tissue repair27. Feezor and co-workers have analyzed temporal patterns of global gene 
expression following infliction of murine cutaneous burn injuries47. We compared the 
expression of EDC genes during wound healing in their dataset available via the Gene 
Expression Omnibus repository (dataset GDS353; http://www.ncbi.nlm.nih.gov/geo/). SPRR 
genes (Figure 4A, large pink bar) have a very characteristic expression pattern which is 
clearly different from the classical cornified envelope precursor proteins involucrin and 
loricrin (indicated by arrows) and is only matched by S100A8 and S100A9 (short pink bar), 
two genes previously implicated in wound healing187. 
The above data provide insight into a more global function for SPRR proteins in 
wound healing that might not be restricted to stratified squamous epithelia. Along these lines 
of thinking, we extended our literature-based meta-analysis to other tissues. This analysis  




Figure 3. Quenching of Reactive Oxygen Species by SPRR proteins in vitro and in vivo. A, 
Representation in one-letter code of the human SPRR1B protein sequence: cysteine (red) and 
histidine (blue) residues are indicated. B, Relative singlet oxygen quenching potential of equimolar 
solutions of purified SPRR1B protein either untreated (bar 1, black), NEM-treated (bar 2, red), DEPC-
treated (bar 3, blue) or treated with both reagents (bar 4, violet). The quenching ability of untreated 
protein was set at 100%. C, Quantification of singlet oxygen quenching in living OKF cells expressing 
various amounts of SPRR proteins. SPRR1 expression levels are indicated below the bar graph (1: 
control cells; 2: OKF-∆1; 3: OKF-∆2). D, Quantification of singlet oxygen quenching in living HeLa 
cells. Both control (bar 1) and HeLa cells overexpressing SPRR1B69 (bar 2) are shown. E, 
Measurement of DNA strand breaks induced in HeLa control cells (black graph) and cells ectopically 
expressing SPRR1B (red graph) by using the comet assay26. For each cell line at least 200 individual 
cells were quantified. Inserts 1 and 2 represent respectively untreated and H2O2 treated single HeLa 




proved that SPRR genes are highly up-regulated in more than 50 microarray screens from 
divergent tissues and cell types (Figure 4B), often linked to stress or tissue remodelling. For 
example, in cardiomyocytes, SPRR was identified as a cardioprotective protein after ischemic 
stress140. During ischemia/reperfusion high levels of ROS are produced in the heart, which 
can be detoxified by massively increased SPRR expression in the same way as shown here 
for cultured cells. SPRR protein levels increase by more than 200 fold in response to bacterial 
colonization of the intestine73 and here SPRRs are also likely to fulfil an antioxidant function. 
Bile duct ligation resulted in SPRR expression and subsequent adaptation of the biliary 
barrier133. It is interesting to mention that also in this specific case a direct link has been laid 
between SPRR expression and in vitro cell migration of human biliary epithelial cells34. During 
development of the mammary gland128 as well as during nerve regeneration after axotomy13, 
SPRR proteins appear to function as tissue remodellers. In the injured axons, SPRR 
expression was mainly found in the axonal growth cones where it localises to cellular 
membrane ruffles, very similar to the situation described here for migrating keratinocytes. 
Additionally the same study has revealed that down-regulation of SPRR in axotomized 
neurons impaired directed axonal outgrowth13. 
 
Figure 4. Meta-analysis of SPRR 
expression during cutaneous wound 
healing and in non-squamous tissues. 
A, Effect of cutaneous burn wounding on 
gene expression in the epidermal 
differentiation complex (EDC) on mouse 
chromosome 3. Microarray data are from 
the Gene Expression Omnibus repository 
(http://www.ncbi.nlm.nih.gov/geo/ 
dataset GDS353). Expression levels of 4 
experimental conditions are shown: 
unburned skin (control), burn skin 
harvested 2 hours (2h), 3 days (3d) and 
14 days (14d) after injury47. The positions 
of involucrin and loricrin are indicated by 
arrows. The SPRR gene family and the 
S100A8 and S100A9 genes are marked 
with pink bars. B, Graphical representation 
of the number of studies describing SPRR 
up-regulation in non-squamous tissues 
(grouped per organ) following stress or 
injury. The corresponding references are 
supplied in Table 2, Chapter I. 
 
The above data disclose a novel and unexpected role of SPRR proteins in global wound 
healing, which links ROS protection and tissue remodelling. How can this function be 
reconciled with their canonical function restricted to skin keratinisation? Previously we have 
proposed that the differential regulation of the 11 members of the SPRR gene-family 
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provides a molecular mechanism for effectively adapting the barrier function in the 
uppermost layer of our skin. This differential regulation of highly homologous genes with 
redundant functions that respond selectively to various forms of stress or tissue 
requirements, allows a tightly regulated protein dosage that provides optimal barrier function 
to different squamous epithelia, while allowing adaptation to diverse external insults18. In the 
same way, a similar protein dosage mechanism is also likely to provide all tissues with an 
efficient, finely tuneable antioxidant barrier, specifically adapted to the tissue involved and 
the damage inflicted. The recognition of SPRRs as efficient cell protective proteins, linking 
ROS detoxification with cell migration, will provide new possibilities to study and manage 
tissue repair and wound healing at a molecular level. 
 
 
Materials and Methods 
 
Human skin equivalents  
Sections from full-thickness human skin equivalent wounds, induced by liquid 
nitrogen freezing, were obtained from Dr. A. El Ghalbzouri (Department of Dermatology, 
Leiden University Medical Centre) and were previously described43. Expression of SPRR was 
assessed by immunostaining using a monospecific rabbit-antibody69 and counterstained with 
hematoxylin. The mono-specificity of the antibodies was tested on HeLa cells (which do not 
express SPRR proteins), transfected with the various SPRR family members, both for 
Western blotting and immunostaining69. 
 
shRNA mediated knockdown  
For the downregulation of SPRR, we constructed  an episomal expression vector, 
named pESuper, derived from pECV25 (ATCC) and a fragment of pSuper15 containing the 
H1-RNA promoter and polylinker sequence. Oligonucleotides containing the SPRR specific 
target sequences GCAGTGCAAGCAGCCCTGC (siRNA1) and CGCCAAAGTGCCCAGAGCC 
(siRNA2) were used for the shRNA-mediated knockdowns. They target both SPRR1 and 
SPRR2 genes. Immortal OKF keratinocytes (OKF6/TERT-235), which do not express SPRR3 
and SPRR4 (our  unpublished observations) were kindly provided by Dr. J.G. Rheinwald 
(Harvard Medical School, Boston), cultured in defined Keratinocyte-SFM (KSFM; GIBCO) as 
described35 and transfected with the above mentioned pESuper constructs, or empty vector 
control, by using the Amaxa nucleofector according to the manufacturer’s protocol (Lonza 
AG, Cologne, Germany). Stable cell-lines, designated OKF-∆1 (OKF cells containing the 
pESuper vector with siRNA1), OKF-∆2 (containing pESuper with siRNA2), and OKF control 
cells (empty pESuper vector), were grown until confluence. One day thereafter scratch 
wounds were made with a yellow pipette tip, the medium was exchanged for KSFM without 




remaining free of cells was quantified using Adobe Photoshop and Biorad Quantity One 
software. 
 
Protein chemistry  
SPRR proteins were produced by using IPTG induction of Escherichia coli BL21 
(DE3)*RP (Stratagene, La Jolla) bacteria transformed with a pET-vector (Novagen) 
containing a full-length SPRR cDNA insert. Bacterial pellets were lysed by freeze-thawing in 
25mM sodium-citrate (pH 3.6), 1mM EDTA, 1mM DTT. Under these conditions SPRR proteins 
remained soluble. Upon centrifugation at 37,000 rpm in a Ti60 rotor (Beckman) the 
supernatant was further purified using a 6 ml Resource S column (GE Healthcare). The 
buffer was exchanged to 10mM sodium-phosphate (pH 7.0) and the SPRR proteins were 
stored at -80ºC. Sulfhydryl groups of cysteines were modified with N-ethylmaleimide (NEM) 
and histidine residues with diethylpyrocarbonate (DEPC). The purity of all proteins as well as 
all modifications were confirmed by mass spectrometry. 
 
ROS measurements and toxicity assays  
Flash-photolysis experiments were performed using a Continuum Surelite I YAG-laser. 
1O2 was detected with a Judson Germanium G-050 photodiode coupled to a Judson 
preamplifier. All samples were measured in a glass cuvette with magnetic stirrer in D2O 
containing Rose Bengal as sensitizer. The comet assay was performed as previously 
described26 and quantified using ColourProc, an in-house software program kindly provided 
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Figure S1. Reactive oxygen 
quenching of SPRR4 protein in vitro. 
A, Representation in one-letter code of the 
human SPRR4 protein sequence: cysteine 
residues are indicated in red. Note that 
SPRR4 does not contain histidine residues. 
B, Relative singlet oxygen quenching 
potential of equimolar solutions of purified 
SPRR4 protein either untreated (bar 1, 
black), NEM-treated (bar 2, red), DEPC-
treated (bar 3, blue) or treated with both 
reagents (bar 4, violet). The quenching 







Movie S1. Involvement of SPRR proteins in cell migration. OKF keratinocytes were transiently 
transfected with pEGFP-SPRR1B and analyzed with the Olympus IX81 live-imaging station. Time-lapse 
images were recorded for 200 min at intervals of 2 min. Note the localization of SPRR proteins to 
membrane ruffles at the leading edge of migrating cells. This pattern was not observed in parallel 
cultures expressing pEGFP-actin or pEGFP-tubulin fusion proteins and was confirmed by SPRR-
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The cornified cell envelope (CE) is a specialised structure assembled beneath the 
plasma membrane of keratinocytes in the outermost layers of the epidermis. It is essential 
for the physical and permeability properties of the skin’s barrier function. Our skin is 
continuously exposed to atmospheric oxygen and threatened by reactive oxygen species 
(ROS). Here we identify the CE as a first line of antioxidant defence and show that the small-
proline-rich (SPRR) family of CE precursor proteins play a major role in ROS detoxification. 
Cysteine residues within these proteins are responsible for ROS quenching, resulting in inter- 
and intramolecular S-S bond formation, both in isolated proteins and purified CEs. The 
related keratinocyte-proline-rich protein (KPRP) is also oxidized on several cysteine residues 
within the CE. Differences in antioxidant potential between various SPRR family members are 
likely determined by structural differences rather than by the amount of cysteine residues 
per protein. Loricrin, a major component of the CE with a higher cysteine content than 
SPRRs, is a weak ROS quencher and oxidized on a single cysteine residue within the CE. It is 
inferred that especially SPRR proteins provide the outermost layer of our skin with a highly 
adaptive and protective antioxidant shield. 





Reactive oxygen species (ROS) can have beneficial effects as they operate as 
regulatory molecules in multiple intracellular signalling pathways, for instance as the first 
danger signal during wound healing to attract immune cells, or merely as chemical sterilizers 
in our host defence mechanism28,48,118. Nevertheless in general ROS are considered as toxic 
compounds. In the mid-1950s, Denham Harman proposed ROS as essential determinants of 
the ageing process, since excessive ROS can damage lipids, proteins and nucleic acids 
leading to cellular dysfunction and death65. More recently, altered ROS levels were implicated 
in diseases such as Alzheimer, Parkinson, atherosclerosis, rheumatoid arthritis, diabetes, 
psoriasis, cystic fibrosis, hypertension, ischemia and cancer12,202.  
Of all tissues, our skin is exposed to the highest ROS levels. It is, besides the lungs 
and eyes, the only organ in direct contact with atmospheric oxygen, including air pollutants 
and the natural deleterious ozone gas. The skin has been shown, as early as 1851, to 
directly take-up oxygen via cutaneous respiration194. Skin also faces high levels of ROS which 
are induced during wound healing against invading bacteria118. In addition, various types of 
ROS, like the superoxide anion (O2.-), the hydroxyl radical (HO.), hydrogen peroxide (H2O2) 
and singlet oxygen (1O2) are generated following exposure to UV radiation derived from 
natural sunlight139,164. In order to cope with excessive ROS and to endow a protective 
antioxidant barrier, our skin has evolved several detoxification mechanisms95,167. These 
antioxidants can be classified into two major groups, enzymes and low molecular weight 
antioxidants (LMWA). The LMWA group contains compounds such as ascorbic acid (vitamin 
C), tocopherol (vitamin E), uric acid, glutathione, and ubiquinol, all capable of directly 
scavenging ROS95. The enzyme group contains superoxide dismutase, catalase, peroxidase 
and glutathione reductase, which in turn can actively detoxify ROS122,164. Beside the two 
major antioxidant classes, other proteins function in this detoxification process, either by 
direct quenching or indirect regulation of signalling pathways that activate the antioxidant 
defence system28,202.  
Many antioxidants are present at higher levels in the epidermis as compared to the 
dermis, correlating with decreasing ROS levels towards the inner layers of our skin167. In fact 
it was shown that the most external, cornified layer of the skin already provides sufficient 
antioxidant protection following a challenge with for instance ozone186. Within the cornified 
layer, a specialised structure surrounding the terminally differentiated keratinocytes, named 
the cornified cell envelope (CE), is responsible for the physical and permeability properties of 
the skin’s innate barrier function19,84. During the epidermal differentiation process several 
proteins are expressed from the epidermal differentiation complex (EDC) localised on human 
chromosome 1q21 (e.g. involucrin, loricrin and the SPRR or LCE protein families)18,19. These 
cornified envelope precursor proteins contain highly similar head and tail domains, rich in 
lysine and glutamine, which are involved in transglutaminase-mediated cross-linking in the 
outermost layers of the skin10,84. On cross-linking on the cell periphery they form, together 




We recently showed that SPRR proteins are able to detoxify ROS during wound 
healing192. Interestingly, this novel function of SPRR is not only restricted to squamous 
epithelia. Indeed, on injury, SPRR protein expression massively increases at the edge of the 
wound in various types of tissues. This increase directly lowers the amount of ROS at the 
wounded site and is essential to allow proper cell migration during the wound healing 
process. Since SPRR proteins evolved together with all other EDC genes for their role in the 
assembly of the CE190, we inferred that the antioxidant potential of the SPRR proteins could 
also provide the skin with an antioxidant barrier. In this paper, we identify the CE as a first 
line of antioxidant defence, as it is able to directly quench ROS. We show that the SPRR 
family of CE precursor proteins, which were originally identified as UV-inducible genes86, play 
a major role in ROS quenching both in vitro and in vivo, mainly due to their cysteine 
residues.   
 
 
Results and Discussion 
 
In a first instance we examined the potency of purified CEs in ROS quenching. CEs 
from sunburned peeled skin were isolated as previously described123 and measured with an 
in-house Flash-photolysis set-up, which is graphically represented in Figure 1a. With this 
technique it is possible to quantitatively measure the time-resolved near-infrared 
luminescence of singlet oxygen, one of the major oxidizing species in skin94. All reactions 
were performed in a glass cuvette with magnetic stirrer, containing Rose Bengal (RB), to 
generate singlet oxygen, and D2O, allowing a longer singlet oxygen lifetime89. The advantage 
of this system is that the quenching potential of any compound, whether it is a purified 
protein, a living cell, or in this case, isolated intact (Figure 1b) or sonicated CEs (Figure 1c) 
can be quantified. A typical time-profile of the singlet oxygen luminescence in D2O is shown 
in Figure 1d (solid line). Addition of intact (dashed line) or sonicated CEs (dotted line) both 
resulted in a substantial decrease in the singlet oxygen lifetime, indicating their direct 
involvement in ROS quenching. The rate constant of singlet oxygen decay, which can be 
calculated from the slopes in Figure 1e, is significantly increased in sonicated CEs (dotted 
line) as compared to intact ones (dashed line). The CE consists of a protein envelope coated 
by a lipid envelope68,130. Sonication is likely to result in a better accessibility of the internal 
proteinaceous CE components, suggesting that the protein part of the CE might be 
responsible for the antioxidant properties of the CE. It can, however, not be completely 
excluded that oxidation products, possibly generated during sonication, also contribute to the 
higher quenching ability of sonicated CEs. Analysis of CEs from different body sites has 
previously revealed that loricrin and the SPRR protein family together always comprise about 
85-90 percent of the total CE protein mass with relative molar ratios ranging from >100-1 in 
trunk epidermis to 5-1 in footpad epidermis and 3-1 in forestomach epithelium93,174.  
In order to compare the individual antioxidant properties of these major CE precursor 
components in vivo, stable cell lines were established expressing loricrin (HFLor), SPRR1B




Figure 1. Flash-photolysis detection of the singlet oxygen quenching by cornified cell 
envelopes. a, Graphical representation of the used Flash-photolysis set-up. Singlet oxygen is 
produced by laser excitation at 532nm of the samples, containing D2O and Rose Bengal as sensitizer. 
The subsequent decay of singlet oxygen is measured at 1270nm with a photodiode. b-c, Photographs 
of purified, intact (b) and sonicated (c) cornified cell envelopes isolated from human skin. Scale bar = 
15 µm. d, Typical time-profile of the luminescence of singlet oxygen (solid line), which is significantly 
reduced after addition of intact (dashed line) or sonicated CEs (dotted line). e, Singlet oxygen decay 
(kdecay) plotted against increasing concentrations of intact (dashed line) or sonicated CEs (dotted 
line). 
 
(HF1B), SPRR2A (HF2A), SPRR3 (HF3), SPRR4 (HF4) or empty vector control (H24) in HeLa 
cells, which do not express these proteins (our unpublished observation). It appeared that 
each of these ectopically expressed proteins potentiated the ROS quenching ability of the 
transfected cells (Table 1). The relative percentage of quenching was calculated by dividing 
the cellular quenching rate constants by the respective protein expression levels determined 
via Western blotting. The highest effect was observed with cells expressing SPRR4 (set at 
100%), followed by the other SPRR proteins (approximately 50% efficiency) and loricrin with 




to the various proteins in question, the Flash-photolysis measurements were repeated with 
purified proteins. Due to the insolubility of loricrin it was not possible to purify this protein 
and include it in the in vitro study. As far as SPRRs are concerned, similar rate constants 
were identified for SPRR1B, SPRR2A, and SPRR3 (Table 2), and again a higher value was 
observed for SPRR4, consistent with the cellular data. This indicates that the data obtained 
in living cells (Table 1) are the result of direct ROS quenching by the ectopically expressed 
proteins. 
 
Table 1. In vivo quenching of reactive oxygen species by living cells ectopically expressing loricrin or 
one of the SPRR proteins  
Cell line Rate constant1 SD Relative expression2 Relative % quenching3
HFLor 7,540E-02 6,03E-03 1,76 25,3 
HF1B 4,169E-01 1,02E-02 4,71 52,3 
HF2A 2,274E-01 2,49E-02 2,86 47,0 
HF3 1,898E-01 1,14E-02 2,18 51,4 
HF4 1,692E-01 1,22E-02 1,00 100,0 
H24 6,900E-03 7,72E-04 -4 -
1 In vivo rate constants (L x C-1 x s-1) obtained by Flash-photolysis with cultured cells are depicted in 
singlet oxygen lifetime (L) per cell (C) per second (s). 
2 The relative expression levels were calculated by western blot. The band intensities were quantified 
after detection with a FLAG antibody and the expression level of FLAG-SPRR4 was set at 1. 
3 The relative % quenching was calculated by correcting the individual cellular rate constants for the 
expression level of the particular proteins 
4 – The value could not be calculated since no protein was ectopically expressed in this cell line.  
 
Table 2. In vitro quenching of reactive oxygen species by purified SPRR proteins 
Protein 
Rate 
constant1 SD Relative % quenching No. of cysteines 
Loricrin ND ND ND 19 
SPRR1B 6,078E+08 9,75E+07 50,9 8 
SPRR2A 6,755E+08 4,62E+07 56,5 11 
SPRR3 6,318E+08 1,11E+08 52,9 8 
SPRR4 1,195E+09 1,63E+08 100 7 
SPRR4NEM 4,650E+07 3,46E+06 3,9 -2
1 In vitro rate constants (L x M-1 x s-1) obtained by Flash-photolysis with purified proteins are depicted 
in singlet oxygen lifetime (L) per mole protein (M) per second (s). 
2 All cysteine residues in this sample were inactivated by NEM modification. 
The extent of modification was confirmed by mass spectrometry.  
 
 
While performing these in vitro experiments we observed that singlet oxygen, 
produced via illumination of RB, induced SPRR protein multimerisation (Figure 2a, lane 3 
arrows). This multimerisation was not observed in the presence of RB without irradiation 
(lane 2), indicating that the production of ROS directly affects the SPRR proteins. Indeed, 
various other oxidising compounds induced the formation of similar SPRR multimers (Figure 
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2b). All SPRR proteins contain besides proline residues, high amounts of cysteine, a known 
redox-regulated amino acid involved in ROS quenching and signalling in many proteins28,125. 
Specific inactivation of the cysteine residues in SPRR1B (Figure 2c), SPRR2A (Figure 2d), 
SPRR3 (Figure 2e) and SPRR4 (Figure 2f) by N-ethylmaleimide (NEM) prevented both inter- 
and intramolecular S-S bond formation (compare lanes 2 and 4). Addition of ROS to the 
untreated SPRR proteins (lanes 1) resulted in the formation of dimers and trimers (lanes 2), 
and tetramers in the case of SPRR4. Interestingly, SPRR1B, SPRR2A, and SPRR3 appear also 
to be subjected to intramolecular S-S bond formation, as shown by the appearance of 
protein forms migrating faster than the monomeric form. SPRR multimerisation is gradually 
reverted upon addition of increasing amounts of -mercaptoethanol (Figure 2g). To prove 
the direct implication of cysteine residues and S-S bond formation in ROS quenching, the 
singlet oxygen decay rate of NEM treated SPRR4 was measured. The results revealed that by 
specifically inactivating all cysteine residues in SPRR4 the quenching activity was almost 
completely inhibited (Table 2; bottom row).  
 
Figure 2. SPRR multimerisation 
induced by cysteine oxidation. a, 
PAGE analysis of untreated (lane 1), 
Rose Bengal treated (lanes 2, 3) and 
illuminated SPRR4 (lane 3). Arrows 
indicate dimer, trimer, and tetramer 
formation. b, Multimerisation of SPRR4 
by various types of ROS: no treatment 
(lane 1), hydrogen peroxide (lane 2), 
peroxyradical (lane 3), bromate radical 
(lane 4) illuminated Toluidine Blue 
(lane 5), Chlorin e6 (lane 6). c-f, H2O2 
induced multimerisation of SPRR1B (c), 
SPRR2A (d), SPRR3 (e), and SPRR4 (f) 
is inhibited by N-ethylmaleimide: mock-
treated (lane 1), H2O2 (lane 2), NEM 
(lane 3); NEM followed by H2O2 (lane 
4). g, Reversion of H2O2-mediated 
SPRR4 multimerisation (lane 2) with 
increasing concentrations of -










In summary, we have shown that the CE is directly involved in ROS quenching and 
that sonication likely results in a better accessibility of the internal proteinaceous CE 
components leading to an increased antioxidant potential in our measuring system. From the 
major CE protein components the SPRR family members are capable of directly detoxifying 
ROS both in vitro and in cultured cells, mainly due to their cysteine residues. The superior 
ROS quenching by SPRR4 is not due to a higher content of cysteine residues since all SPRR 
proteins contain similar amounts of cysteines (Table 2). The same conclusion can be drawn 
by comparing the quenching potential of loricrin and SPRR4. Loricrin contains almost 3 times 
as many cysteines than SPRR4, but is nevertheless the weakest ROS quencher (see Tables 1 
and 2).  
Structural studies by NMR and circular dichroism predicted SPRR1, SPRR2 and SPRR3 
proteins to consist of repeating β-turns in their central domain, resulting in an ordered 
spring-like structure173 in which the proline content determines the rigidity of the different 
SPRR proteins19. Secondary structure predictions (BetaTPred2) of SPRR proteins are 
represented in Figure 3. β-turns mainly consist of 4 amino acids, stabilised by cross-strand 
interactions112. Since the repeats in the central domain of SPRR consists of 8 to 9 amino 
acids, depending on the SPRR isoform, they are likely to form a chain of repetitive turns in 
which the cysteine residues would be able to form intramolecular S-S bonds to stabilise the 
structure. The ROS-induced appearance of more compact monomeric protein forms with a 
higher mobility in PAGE (Figure 2c-e) indicates that such intramolecular S-S bonds are 
indeed formed following ROS quenching. Interestingly, SPRR4 predictions disclosed a 
structure containing less β-turns in the central domain and two α-helices at the N-terminus 
(Figure 3). This conformation, related to the lower proline content, indicates that SPRR4 
might be a more flexible protein. As a result, cysteine residues of SPRR4 would be more 




Figure 3. Secondary structure prediction of the highly homologous SPRR proteins. 
Graphical representation of the secondary structure of the various SPRR protein sub-classes. -Turn 
sequences predicted in all SPRR proteins are indicated by zigzag structures and the two -helices in 
SPRR4 are also shown. The characteristic SPRR-repeats in the central domain of the proteins are 
boxed. 
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To ascertain whether S-S bond formation is actually responsible for ROS quenching in 
isolated CEs (shown in Figure 1), the oxidation state of cysteine residues in CE components 
was analysed by LTQ-Orbitrap tandem mass spectrometry. Sonicated CEs were first mock or 
H2O2 treated and subsequently modified with NEM, which only reacts with the free thiol 
groups. The remaining oxidised cysteines were reduced by addition of dithiothreitol and then 
modified with iodoacetamide, a second thiol reactive compound. In this way cysteine 
residues engaged in S-S bonds within the CE are selectively modified with iodoacetamide 
whereas free thiol groups are modified with NEM. Following tryptic digestion, many peptides 
containing oxidation sensitive cysteine residues were found. By only gating iodoacetamide 
labelled peptides originating from EDC genes or known cornified envelope precursor genes 
(Table 3), multiple cysteine-containing SPRR peptides appeared to be subjected to H2O2 
induced oxidation, demonstrating that SPRR proteins fulfil a major role in ROS detoxification 
within the CE. In addition, cysteine-containing peptides originating from loricrin and filaggrin-
2, one of the fused gene family members in the EDC142, were identified to be involved in the 
formation of S-S bonds. One of the most recently identified EDC genes, keratinocyte proline-
rich protein (KPRP)97 showed, similar to SPRR, numerous oxidised cysteines residues. To our 
knowledge, this is the first direct evidence that KPRP is a CE precursor protein and that it is 
involved in ROS detoxification. 
 
Table 3. Mass spectrometric identification of CE peptides involved in S-S bonds after oxidation 
Sequence ∆p.p.m. Peptide score z Protein 
CPEPC*PPPK -0,87 49 2
SPRR2A, SPRR2B, SPRR2D, 
SPRR2E, SPRR2F, SPRR2G 
C*PEPCPPPK 0,91 41 2
SPRR2A, SPRR2B, SPRR2D, 
SPRR2E, SPRR2F, SPRR2G 
C*PPVTPSPPC*QPK 1,48 60 2 SPRR2E, SPRR2F 
QPC*QPPPVC*PTPK 0,41 46 3
SPRR2A, SPRR2B, SPRR2D, 
SPRR2E, SPRR2G 
QPTPQPPVDC*VK -1,25 51 2 Loricrin 
FGGQGNQFSYIQSGC*QSGIK -0,19 94 2 Filaggrin-2 
GGQGHGC*VSGGQPSGC*GQPESN 
PC*SQSYSQR 1,85 127 3 Filaggrin-2 
C*PVEIPPIR 1,12 60 2 Keratinocyte proline-rich protein 
IEISSPC*C*PR -1,81 59 2 Keratinocyte proline-rich protein 
GRPAVC*QPQGR 0,35 36 3 Keratinocyte proline-rich protein 
LDQC*PESPLQR -1,47 66 2 Keratinocyte proline-rich protein 
FSTQC*QYQGSYSSC*GPQFQSR -0,23 60 3 Keratinocyte proline-rich protein 
TSFSPC*VPQC*QTQGSYGSFTEQHR 0,3 80 3 Keratinocyte proline-rich protein 
LDTEAPYC*GPSSYNQGQESGAGC* 
GPGDVFPER -0,29 117 3 Keratinocyte proline-rich protein 
 
Cysteine residues involved in the formation of S-S bonds were identified via iodoacetamide labelling 
(see Materials and Methods) and are indicated by C*. Mass deviations between measured and 
theoretical values of the various peptides are given as ∆p.p.m. (absolute values <5 are considered as 
accurate measurements). The respective peptide scores (reflecting the reliability of the assignment of 
the peptide sequence) and z-values (charge of the peptide) are also provided. All Mascot 
identifications were manually validated and gated against a subset of the SwissProt database 





Overall, our data indicate that all SPRR proteins have the ability to contribute to the 
antioxidant properties of the CE, but to a different extent, depending on the amount and 
accessibility of their cysteine residues. Our data suggest that the CE, as part of the 
outermost layer of our skin, constitutes the first line of antioxidant defence and provides 
protection against the high levels of ROS engendered by atmospheric oxygen and UV 
irradiation. UV light for instance can induce ROS production and trigger lipid 
peroxidation46,132. Within the stratum corneum the lipid envelope is in close contact with the 
proteinaceous CE components130. In this way the majority of ROS can be directly secured by 
the SPRR CE precursor proteins at the periphery of cells. This will permit a more efficient 
handling of residual cell-infiltrating ROS by the LMWA and enzymatic antioxidants. Besides 
triggering ROS production, UV-irradiation of the skin has previously been shown to induce 
SPRR4 expression associated with thickening of the stratum corneum17. As the SPRR proteins 
can be differentially regulated by a complex panel of interdependent transcription factor 
complexes50, this stress-induced activation is likely part of the skin’s antioxidant defence 
against subsequent ROS damage. We have previously inferred that the differential regulation 
of highly homologous SPRR proteins constitutes the basis for an adaptive epithelial barrier 
function. The data provided here demonstrate that SPRR proteins also provide the outermost 
layer of our skin with a highly adaptive and protective antioxidant shield.  
 
 
Materials and Methods 
 
Flash-photolysis 
Singlet oxygen, O2(1g), quenching rate constants (kq) were determined by 
monitoring its time-resolved luminescence following Nd:YAG laser (Continuum, Santa Clara) 
excitation of Rose Bengal at 532 nm. This generates singlet oxygen via energy transfer from 
the triplet state of Rose Bengal to ground state molecular oxygen. The subsequent 
luminescence at 1270 nm was detected with a Judson Germanium G-050 photodiode coupled 
to a Judson preamplifier (Judson Technologies, Montgomeryville, PA). All samples were 
measured in a glass cuvette with magnetic stirrer in 300µl D2O (Merck, Darmstadt, Germany) 
with 5µl 10mM Rose Bengal (Sigma-Aldrich, St Louis, MO) added before any quencher was 
supplied. The luminescence decay of singlet oxygen was averaged over 256 measurements 
per concentration of quencher and was independently measured for at least six different 
concentrations per sample. At each concentration a luminescence trace was obtained and 
fitted with a single exponential. The quenching rate constants for purified CEs, SPRR proteins 
and CE precursor expressing cells were calculated from the singlet oxygen decay rates 
(kdecay) plotted against the concentrations of quencher. The cellular rate constants were 
divided by the respective protein expression levels, quantified by Western-blot with a 
monoclonal anti-FLAG antibody (clone M5, Sigma), to obtain the relative percentage of 
quenching. 
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SPRR protein production and purification 
SPRR proteins were produced by using isopropyl-β-D-thio-galactoside induction of 
E.coli BL21 (DE3)*RP (Stratagene, La Jolla) bacteria transformed with a pET-vector (Merck) 
containing a full-length SPRR cDNA sequence. Bacterial pellets were lysed by freeze-thawing 
in 25mM sodium-citrate (pH 3.6), 1mM EDTA, 1mM dithiothreitol in which the SPRR proteins 
remained soluble. Upon centrifugation at 37,000 rpm in a Ti60 rotor (Beckman-Coulter, Brea, 
CA) the supernatant was further purified using a 6ml Resource S column (GE Healthcare, 
Diegem, Belgium). The buffer was exchanged to 10mM sodium-phosphate (pH 7.0) and the 
SPRR proteins were stored at -80ºC. The purity of all proteins was confirmed by mass 
spectrometry. 
 
SPRR multimerisation and cysteine modification 
All multimerisation experiments were performed using identical molar ratios of 
proteins and oxidising compounds. Singlet oxygen was generated by illumination of Rose 
Bengal (RB), Toluidine Blue (TB) or Chlorine e6 (Ce6), for two minutes with a 500 watt 
halogen lamp. Treatments with all other oxidising compounds were for a period of 10 
minutes. The following final concentrations were used: 10mM H2O2; 0.2mM FeSO4 with 1mM 
H2O2; 10mM KBrO3; 10mM RB; 0.5mM TB; 10mM Ce6. All reactions were performed on ice, 
and equal amounts of protein were loaded on gel, using loading buffer without -
mercaptoethanol. Cysteine residues of SPRR were specifically inactivated by incubation with 
20mM N-ethylmaleimide (NEM; Sigma-Aldrich) for one hour. The modifications were 
confirmed by mass spectrometry. 
 
Secondary structure predictions 




For the generation of stable cell lines full-length SPRR or loricrin cDNA sequences 
were provided with an N-terminal FLAG-tag and introduced into the episomal expression 
vector pECV2511. HeLa cells, which do not express any of these proteins, were transfected 
using DOTAP (Boehringer, Mannheim, Germany), and were grown in DMEM supplemented 
with 10% newborn bovine serum, Pen/Strep, and 300 μg/ml hygromycin. Stable cell lines 
were named HFLor (loricrin), HF1B (SPRR1B), HF2A (SPRR2A), HF3 (SPRR3), HF4 (SPRR4) 
and H24 (empty vector control). For intracellular protein quantification the various ectopically 
expressed proteins were detected on Western blots with monoclonal anti-FLAG antibody 






CE isolation and mass spectrometric characterisation 
Cornified cell envelopes were isolated from sun-burned peeled skin according to the 
previously described procedure123 by boiling the skin pieces in 100mM Tris-Cl (pH 7.5), 2% 
SDS, 1mM EDTA, 10mM DTT. Note the reducing character of this buffer (10 mM DTT), which 
means that CEs will loose all oxidised cysteine residues during the purification procedure and 
are as such isolated in their native form (as composites of transglutaminase-crosslinked 
proteins and lipids).     
For mass spectrometry determination sonicated CEs were oxidized with 10mM H2O2 
followed by NEM.treatment. In this way, all cysteine residues that are in a position to form S-
S bonds will become oxidised, whereas all non-oxidized cysteines will be modified with NEM. 
The samples were subsequently reduced with dithiothreitol and treated with iodoacetamide 
to modify the originally oxidised cysteines. The subsequent procedures and treatments for 
tryptic digestion, stage-tip purification, LTQ-Orbitrap tandem mass spectrometry and Mascot 
analysis are described elsewhere53. Within Mascot all identified peptides were characterised 
via the SwissProt database. All protein identifications were manually validated and gated for 
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Figure S1: Singlet oxygen decay (kdecay) plotted against increasing concentrations of intact (dashed 
line) or sonicated CEs (dotted line) isolated from sunburned peeled skin or from footsole (solid line). 
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Protection against injurious external insults and loss of vital fluids is essential for life 
and is in all organisms, from bacteria to plants and humans, provided by some form of 
barrier. Members of the small-proline-rich (SPRR) protein family are major components of 
the cornified cell envelope (CE), a structure responsible for the barrier properties of our skin. 
These proteins are efficient reactive oxygen species (ROS) quenchers involved not only in 
the establishment of the skin’s barrier function but also in cell migration and wound healing. 
Here, a proteomic analysis of in-vivo SPRR-interacting proteins confirmed their function in 
CE-formation and ROS-quenching and also revealed a novel unexpected role in DNA-binding. 
Direct in-vitro and in-vivo evidence proved that the DNA-binding capacity of SPRRs is 
regulated by the oxidation state of the proteins. At low ROS levels, nuclear SPRR is able to 
bind DNA and prevent ROS-induced DNA damage. When ROS levels increase SPRR proteins 
multimerize and form an effective antioxidant barrier at the cell periphery, possibly to 
prevent the production or infiltration of ROS. At even higher ROS exposure DNA-binding is 
restituted. A molecular model explaining how the intracellular oxidation state of SPRRs likely 
influences their selective protective function is provided. 





The small proline-rich (SPRR) gene family consists of 11 highly homologous members 
which are clustered within the epidermal differentiation complex (EDC) localized on human 
chromosome 1q2118. Together with other EDC genes (e.g. loricrin, involucrin and the LCE 
gene family), the SPRRs are expressed in the upper layers of cornifying tissues18,19. All of 
these genes share significant sequence similarity as they contain lysine- and glutamine-rich 
N- and C-terminal domains which are utilized for transglutaminase cross-linking during the 
building-up of the cornified cell envelope (CE)10,84. This insoluble structure, formed at the 
inside of terminally differentiated keratinocytes, is responsible for the major barrier 
properties of the skin19,147. It provides protection against biological, chemical and mechanical 
insults, prevents the loss of vital fluids and is essential for mammalian life19.  
As the SPRR family members can be differentially regulated by a complex panel of 
transcription factors, SPRR protein dosage can be rapidly modulated upon a variety of 
physiological and environmental stimuli50. By varying the amount of incorporated SPRR 
protein, the biomechanical properties of the CE can be regulated18,174. Increased SPRR 
protein levels within the CE generally results in a more strengthened barrier which provides 
enhanced resistance to external stressors.  
In addition to this canonical function in the establishment of the epidermal barrier, 
we recently showed that SPRR proteins are expressed throughout our body in a variety of 
non-cornifying epithelia192. Within these tissues, SPRR proteins are not cross-linked by 
transglutaminases in a fixed CE-like structure, but form a reversible barrier via disulfide bond 
formation191,192. Upon tissue damage by destructive stimuli, reactive oxygen species (ROS) 
are generated as a defense against invading bacteria and as signaling molecules initiating 
the healing process9,64. As a result, the amount of SPRR proteins massively increases, which 
in turn directly detoxifies ROS and promotes cell migration. While quenching ROS via their 
cysteine residues, SPRR proteins multimerize and form an antioxidant shield at the cell 
periphery that protects cellular components and the tissue as a whole192. Likewise, SPRR 
proteins confer antioxidant properties to the CE and form the skin’s first line of antioxidant 
defense against atmospheric oxygen and UV irradiation191.  
We have previously shown that SPRR proteins are efficient ROS quenchers and 
provide protection against ROS induced DNA damage191,192. In this paper, we have examined 









Materials and Methods 
Protein interaction screens 
For the isolation and identification of protein interaction complexes, SPRR1B and 
SPRR4 were provided with a Strep-tag and used as bait proteins. Full-length SPRR cDNA 
sequences were cloned in the pEXPR-IBA105-vector as described by the manufacturer (IBA, 
Göttingen, Germany). Immortal OKF keratinocytes (OKF6/TERT-2) were kindly provided by 
Dr. J.G. Rheinwald (Harvard Medical School, Boston) and cultured in defined Keratinocyte-
SFM (KSFM; GIBCO) as described by Dickson et al.35. Transfections with the above 
mentioned pEXPR-constructs, or empty vector controls, were performed by using Amaxa 
nucleofection according to the manufacturer (Lonza AG, Cologne, Germany). Approximately 
109 cells were lysed in cold 50mM Tris-HCl (pH 7.5), 5mM EDTA, 250mM NaCl, 0.1% Triton 
X-100, 7mM CaCl2 supplemented with 5mM NaF, 100mM Na3VO4, 20mM β-
glycerolphosphate, and 1 protease inhibitor cocktail tablet (Roche) per 10ml buffer, all 
freshly added before use. The soluble cell extracts were loaded on a 0.2ml Strep-Tactin 
column (IBA, Göttingen, Germany) and the unbound proteins were washed away. 
Subsequently, a first elution step was performed with 0.5ml wash-buffer (100mM Tris-HCl 
(pH 8.0), 150mM NaCl, 1mM EDTA) supplemented with 50mM DTT. In this way, proteins 
interacting via or stabilized by disulfide bonds were eluted. Residual interaction partners or 
complexes were eluted together with the Strep-tagged SPRR bait protein by using biotin 
elution buffer: 100mM Tris-HCl (pH 8.0), 150mM NaCl, 1mM EDTA, 2mM biotin.  
 
Mass spectrometry analysis and database searching 
Proteins from the individual elution fractions were precipitated by addition of equal 
volumes of 20% trichloroacetic acid121. After three wash-steps with 0.2ml ice cold acetone, 
the proteins were dissolved in 25µl 8M Urea, 0.4M ammonium bicarbonate. The Cysteine 
residues were reduced with 5µl 45mM DTT for 15 min at 50°C and alkylated with 5µl 100mM 
iodoacetamide at room temperature in the dark. Trypsin digestion was performed at 37°C 
overnight121, and the resultant peptides were purified using StageTips145. The LTQ-Orbitrap 
(Thermo Fisher Scientific, Waltham, MA) tandem mass spectrometry analysis was performed 
as previously described53.  
Database searching with Mascot (Matrix Science, Boston, MA) against all human entries in 
Swiss-Prot was performed with the following parameters: peptide tolerance 2ppm, MS/MS 
tolerance 0.5Da, fixed carbamidomethyl modification (C), variable oxidation (M), 2 missed 
cleavages allowed, decoy database option on. The MudPIT scoring algorithm was used with 
an ion score cutoff of 20, with required bold red only. Two unique peptide assignments with 
a significance threshold value p<0.05 were required per protein identification. The datasets 
were imported in Pipeline Pilot (Accelrys Inc., San Diego, CA) in which the respective DTT 
and biotin elution fractions were combined, the empty vector control dataset was subtracted, 
and a protein cutoff score of 40 was applied. The resulting lists of potential binding partners 
(Table S1) were explored with the WEB-based Gene-SeT-AnaLysis Toolkit (WebGestalt) 
(http://bioinfo.vanderbilt.edu/webgestalt/index.php) and the enriched Gene Ontology 
categories were identified by the statistics module208. 
SPRR & ROS regulated DNA binding 
67 
 
SPRR4 cellular localization and toxicity assays 
HeLa cells ectopically expressing FLAG-tagged SPRR4 (HF4), SPRR1B (HF1b), or 
empty vector control (H24) were cultured as previously described191. The localization of 
SPRR4 was assessed by immunostaining using a monospecific rabbit-antibody, obtained after 
immunization of rabbits with the peptides DPCAPQVKKQCPPKG and CPSAQQASKSKQK 
(Eurogentec). The mono-specificity of these antibodies was assessed as previously 
described69. Hoechst 33342 (Sigma) was used as DNA stain. HF4-cells were pre-treated with 
50µM H2O2 for the indicated time points and fixed with cold 80% acetone.  
Comet assays were performed as previously described26,192 and quantified using 
ColourProc, an in-house software program kindly provided by Dr. H. Vrolijk (Department of 
Molecular Cell Biology, Leiden University Medical Center, Leiden). The H2O2 concentrations 
used ranged from 0 to 200µM with at least 1000 comets measured per cell-line. From the 
linear increase in DNA breaks, the calculated slopes were used as a value for the Intracellular 
Quenching Activity (IQA) of the specific cell-lines. For intracellular protein quantification, the 
various ectopically expressed proteins were detected on Western blot with a monoclonal 
anti-FLAG antibody (clone M5, Sigma). 
 
SPRR protein multimerization and DNA binding assays 
SPRR proteins were produced and purified as previously described192. For all DNA 
binding experiments 0.12 pmoles of a linear DNA fragment (3200 bp) was used with a 100 
times molar excess of SPRR4 protein (12 pmoles). Prior to DNA binding, equal amounts of 
protein stock solutions were oxidized using a serial dilution of H2O2 ranging from 0 to 
100mM. Excess H2O2 was removed by gel filtration on Sephadex G10 spin columns or diluted 
out in binding buffer. All binding reactions were performed on ice in 10mM sodium 
phosphate buffer (pH7) and analyzed on 1% agarose gels (for DNA detection) or 15% PAGE 
(for protein detection), using loading buffer without β-mercaptoethanol. Binding of SPRR4 to 
DNA was stable until a salt concentration of 100mM NaCl (results not shown). For the 
analysis of the redox state of the cysteine residues within these diversely oxidized SPRR 
samples, the different protein bands were cut into small pieces. The free thiol groups were 
first labeled with N-ethylmaleimide as previously described191. Subsequently, the cysteines 
engaged in disulfide bonds were reduced by addition of DTT and labeled with iodoacetamide. 
In this way free thiols can be recognized by N-ethylmaleimide labeling and cysteines 
originally engaged in disulfide bonds by iodoacetamide. Thiols already oxidized to sulfenic-, 
sulfinic- or sulfonic acid are not affected by these treatments. The labeled SPRR4 peptides 
were extracted after in-gel tryptic digestion166 and analyzed by OT-Orbitrap tandem mass 
spectrometry53,191. Cysteine modifications of SPRR4 peptides were manually identified in 
Xcalibur (Thermo Fisher Scientific, Waltham, MA) by using the SPRR4 protein sequence 
(NCBI accession no. AF335109) and the calculated peptide masses. All identified peptides 







Identification of SPRR interacting proteins 
SPRR proteins were subjected to a protein-protein interaction screen. Strep-tagged 
SPRR proteins, used as bait, were expressed in human OKF keratinocytes, an immortalized 
cell line normally expressing these proteins upon epidermal differentiation or cell 
migration192. Soluble cell extracts were loaded on a Strep-Tactin column and after removal of 
all non-interacting proteins, SPRR interactors were isolated using a dual elution procedure to 
distinguish between different modes of interaction. In step 1 wash buffer supplemented with 
DTT was used to identify proteins whose interaction is mediated or stabilized via disulfide 
bonds. In step 2 biotin elution buffer was used to elute the remaining interacting proteins. 
Eluted samples were analyzed by LTQ-Orbitrap tandem mass spectrometry and the potential 
binding partners were identified using the Mascot search engine53,137. Peptide hits from the 
empty vector control were subtracted and the identified interactors (Table S1) were 
characterized by the WebGestalt program208.  
 
 
Figure 1. Graphical representation of the Gene Ontology molecular function annotations of the 
identified SPRR interacting proteins. The proteins isolated using SPRR1B (light/dark blue bars) or 
SPRR4 (orange/red bars) as bait were characterized by their Gene Ontology molecular function 
annotations. The ratio of enrichment was calculated by dividing the observed gene number for the 
specific SPRR protein by the expected gene number (green bars; set at one) for each category. The 
light blue and orange part of the bars represents the fraction isolated using wash-buffer 
supplemented with DTT, whereas the dark blue and red part represents the fraction isolated with 
biotin elution buffer. The GO terms for each category which were at least two-fold enriched are given 
in Table 1. 
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Among the gene ontology (GO) molecular function terms, twenty categories (A-T) 
were enriched by more than two-fold for at least one of the SPRRs (Fig. 1). In fact, almost 
all GO categories were enriched for both SPRR1B (light/dark blue bars) and SPRR4 
(orange/red bars), as compared to the expected number of genes calculated by the program 
(green bars; set at one). These categories (Table 1) encompass molecular function terms 
such as “structural constituent of epidermis” (A), “peroxiredoxin activity” (B), “protein 
disulfide isomerase activity” (C), “structural constituent of cytoskeleton” (H), “intramolecular 
transferase activity” (I), and “double-stranded DNA binding” (O). Interestingly, the 
categories “thioredoxin peroxidase activity” (E) and “DNA bending activity” (R), which clearly 
belonged to the highest scores, were selectively enriched for either SPRR1B or SPRR4 
respectively. Several GO annotations were closely related or represented already known 
functions of the SPRR protein family and were therefore clustered (clusters I-III and V in 
Figure 1 and Table 1).  
 
Table 1. Individual and clustered Gene Ontology categories describing the molecular function terms 
of Figure 1. 
Letter GO annotation Cluster 
A Structural constituent of epidermis I 
B Peroxiredoxin activity II 
C Protein disulfide isomerase activity II 
D Protein disulfide oxidoreductase activity II 
E Thioredoxin peroxidase activity II 
F Actin binding III 
G Cytoskeletal protein binding III 
H Structural constituent of cytoskeleton III 
I Intramolecular transferase activity IV 
J Protein phosphatase regulator activity IV 
K Calcium-dependent phospholipid binding IV 
L Unfolded protein binding IV 
M Translation regulator activity IV 
N Nucleic acid binding V 
O Double-stranded DNA binding V 
P Single-stranded DNA binding V 
Q Structure-specific DNA binding V 
R DNA bending activity V 
S DNA helicase activity V 
T RNA helicase activity V 
 
Cluster Molecular function term 
I Epidermal cornification 
II ROS quenching 
III Cytoskeletal protein binding 
IV Diverse 




The remaining set of GO terms, which could not be grouped under a single denominator, 
contains diverse broad molecular functions (cluster IV). The identified groups contain one 
molecular function term involved in epidermal cornification, four terms in ROS quenching, 
three in cytoskeletal protein binding, and seven in nucleic acid binding (Table 1). Especially 
this latter molecular function was unexpected. 
 
Cellular localization of SPRR is subjected to ROS treatment 
To ascertain whether SPRR proteins are actually involved in the identified molecular 
functions, their cellular localization was analyzed. Immunofluorescence staining with a SPRR4 
monospecific antibody revealed mainly cytoplasmic localization in HeLa cells ectopically 
expressing FLAG-tagged SPRR4 (HF4) (Fig. 2). Within the cytoplasm, ordered fiber-like 
structures can be observed (Fig. 2A), indicating that SPRR proteins are at least in close 
proximity to some cytoskeletal proteins. In addition, minor but consistent nuclear SPRR4 
staining was observed (Fig. 2A-C). Immunofluorescence staining against the N-terminal 
FLAG-tag showed similar cytoplasmic and nuclear localization, further proving the specificity 
of the SPRR4 antibody (data not shown). Interestingly, the nuclear localization of SPRR4 
changed upon H2O2 treatment of the cells (Fig. 2A-E). After a ROS challenge, SPRR proteins 
shifted towards the cytoplasm where they preferentially localized to the cytoplasmic 
membrane. Mock treatment followed by a similar incubation period did not result in this 
altered localization (data not shown).  
 
 
Figure 2. The cellular distribution of SPRR4 is affected by ROS. Immunofluorescence detection of 
SPRR4 expression (A-E) in HeLa cells ectopically expressing FLAG-tagged SPRR4 (HF4). DNA was 
counterstained with Hoechst (F-J).  The cells were subjected to ROS treatment with 50µM H2O2 for a 
time period of 0 (A,F), 5 (B,G), 10 (C,H), 15 (D,I), or 20 (E,J) minutes. 
 
We have previously shown that SPRR1B protects against H2O2 induced DNA breaks192. 
Hence we investigated also the effect of SPRR4 on ROS induced DNA breakage and 
compared it to SPRR1B. As a control, the increase in DNA breaks after addition of various 
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concentrations of H2O2 to empty vector control cells (named H24) was analyzed using a 
comet assay. From the linear increase in DNA breaks after addition of H2O2, the calculated 
slope was used as a value for the intracellular quenching activity (IQA) of a specific cell-line 
(Table 2). Ectopic expression of SPRR1B (HF1b) resulted in a decrease in the amount of DNA 
breaks and consequently in a lower slope and thus a higher IQA. Although the expression 
level of SPRR4 (HF4) was clearly lower as compared to SPRR1B, it gave a similar reduction in 
the amount of DNA breaks, indicating its superior relative intracellular quenching activity 
(RIQA) (almost 5-fold increase; Table 2, last column). 
 
Table 2. Quantification of ROS induced DNA breaks in HeLa cells ectopically expressing SPRR1B, 








none H24 0,089 ± 0,009 11,15 - 1,00 
SPRR1B HF1b 0,050 ± 0,002 19,84 1 1,78 
SPRR4 HF4 0,049 ± 0,001 20,08 0,21 8,58 
1 Intracellular Quenching Activity (IQA) is calculated as 1/slope 
2 Relative IQA (RIQA) is corrected for the relative expression level of the ectopically expressed SPRR 
proteins 
At least 1000 comets were analyzed for each cell line. 
 
 
SPRR proteins bind directly to DNA  
In order to evaluate a possible direct binding of SPRR proteins to DNA, 
electrophoretic mobility shift assays were performed with purified SPRR proteins and isolated 
DNA fragments. Addition of increasing amounts of purified SPRR4 protein to a linear DNA 
fragment resulted in a lower mobility of the DNA molecules in agarose gel (Fig. 3A). Similar 
electrophoretic mobility shifts were observed when using purified SPRR1, SPRR2, or SPRR3 
proteins, although a 10 times higher molar excess of protein was required (data not shown). 
These data imply that SPRR proteins have the ability to directly bind to double-stranded 
DNA. This ability was further substantiated by using atomic force microscopy (AFM). Circular 
DNA was visualized in the absence (Fig. 3B) and presence (Fig. 3C) of SPRR4. The analysis 
indicates that SPRR4 has the ability to randomly coat the DNA double helix (coated – and 
uncoated DNA regions are indicated by respectively white and black arrows). Both 
experiments constitute the first direct evidence that SPRR proteins have the ability to bind 
directly to DNA. They further corroborate the protein interactome analysis and the cellular 
localization studies described above. 
 
The oxidation state of SPRR proteins influences their DNA binding capacity 
To investigate the effect of ROS on the DNA binding properties of SPRR proteins, 




initial increasing concentrations of H2O2 a clear gradual decrease in DNA binding was 
observed (Fig. 3D, lanes 1-5). Analysis of the corresponding fractions via PAGE revealed an 
increase in the formation of SPRR multimers (Fig. 3E, lanes 1-5), illustrated by a decrease of 
SPRR monomers and an increase of dimers, trimers and tetramers (Fig. 3F, bars 1-5). 
However, when higher H2O2 concentrations were used (lanes 6-7) a reversion of the above 
mentioned effect was observed as the DNA binding capacity of SPRR4 increased again (Fig. 
3D, lanes 6-7), while the amount of SPRR multimers decreased (Fig. 3E/F, lanes 6-7). 
Surprisingly, the highest H2O2 concentration showed a second drop in DNA binding (Fig. 3D, 
lane 8), whereas the amount of multimers was still decreasing (Fig. 3F, bar 8). 
 
 
Figure 3. DNA binding properties of SPRR proteins depend on their oxidation state. A, addition of 
increasing amounts of purified SPRR4 protein to 0.12 pmoles of a linear DNA fragment (3200 bp) 
results in an altered migration in agarose gel. Zero, 50, 100, and 150 times molar excess of SPRR4 
proteins were respectively used in lanes 1 to 4. B-C, analysis of the SPRR4-DNA complexes with AFM. 
Circular DNA in the absence (B) and presence of purified SPRR4 (C). Black and white arrows 
respectively indicate native DNA regions or DNA regions decorated by SPRR proteins. D-F, SPRR 
protein multimerization and DNA binding are affected by ROS. DNA binding of SPRR4 proteins, 
oxidized with increasing concentrations of H2O2 (1: 0mM, 2: 2.4mM, 3: 4.7mM, 4: 9.0mM, 5: 17.5mM, 
6: 33mM, 7: 64mM, 8: 124mM), is shown in panel D; the same SPRR fractions were also analysed on 
PAGE (panel E). The relative amounts of monomers (blue), dimers (green), trimers (red) and 
tetramers (yellow) on the protein gel of panel E are quantified in panel (F). 
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Disulfide bonds can be broken either by reduction to free thiols or by further 
oxidation to sulfenic-, sulfinic-, and sulfonic acids138,202. These latter forms are characterized 
by different electronic properties which can result in altered protein activities138. To examine 
the effect of these different adducts on SPRR multimerization and DNA binding the redox 
state of the individual protein forms was analyzed. The cysteine residues within the different 
protein bands of lanes 1, 5, and 8 (Fig. 3E) were subjected to a dual labeling step with two 
different thiol-specific compounds to distinguish the various oxidation states (see 
Experimental Procedures). Following tryptic digestion, the extracted SPRR peptides were 
analyzed by OT-Orbitrap tandem mass spectrometry and the redox state of the cysteine 
residues was determined. The results of table 3 indicate that all 7 cysteine residues within 
SPRR4 have the ability to form disulfide bonds following ROS treatment and that the majority 
could be further oxidized to sulfinic-, and/or sulfonic acids. The generally unstable sulfenic 
acid intermediate was not detected.  
 
Table 3. Identified oxidation states of the 7 cysteine residues in SPRR4.  
Sequence 
Observed oxidation 
states p.p.m. Reduced1 Oxidized2 
Highly 
oxidized3 
QQQQC13PPQR Thiol -0,15       
 Disulfide 0,48      
  Sulfonic acid 0,16       
QPC27QPPPVK Thiol 0,66      
 Disulfide -0,72      
 Sulfinic acid -2,36     
  Sulfonic acid 0,95       
C34QETC38APK Thiol/Thiol 0,74      
 Thiol/Disulfide -0,62     
  Disulfide/Disulfide -0,05       
DPC46APQVK Thiol 0,65      
 Disulfide -0,73      
 Sulfinic acid -0,55      
  Sulfonic acid 1,45       
QC54PPK Thiol -0,01     
 Disulfide -0,97      
  Sulfinic acid 0,19       
C67PSAQQASK Thiol -0,52      
  Disulfide 0,11       
 
The various SPRR4 tryptic peptides containing cysteine residues (indicated in red) are represented. 
The number following C represents the position in the primary amino acid sequence (NCBI accession 
no. AF335109). The various protein oxidation states are derived from the protein samples loaded on 
gel in Figure 3E and treated with the following H2O2 concentrations: 1 lane 1 (none); 2 lane 5 (17.5 
mM); and 3 lane 8 (124 mM). Mass deviations between measured and theoretical values of the various 
peptides are given as p.p.m. (absolute values < 5 are considered as accurate measurements). Dark 







Interaction of SPRR with proteins involved in epidermal cornification and ROS 
quenching 
As building blocks of the CE, SPRR proteins are cross-linked to other CE precursor 
proteins thereby providing our skin with a highly adaptive and protective barrier function18,19. 
In order to be able to detect all possible SPRR interacting proteins in our interactome screen 
we have used an immortalized keratinocyte cell line which is still able to differentiate35 and 
express SPRR and other CE precursor proteins. We have previously shown that these cells do 
also express SPRR proteins during cell migration in a scratch-wound assay192. In our screen 
several of the identified proteins such as desmoplakin, desmoglein, and S100 calcium binding 
proteins are known structural constituents of the epidermis (Fig. 1, bars A). Interacting 
proteins were isolated using a dual elution procedure which distinguishes between different 
modes of interaction. The first fraction, eluted with DTT, represents proteins whose 
interaction is mediated or stabilized solely via disulfide bonds. Most structural CE proteins 
were eluted in the second fraction using biotin elution buffer. These proteins are indeed 
known to be cross-linked in the CE by transglutaminases via their lysine and glutamine 
residues19,111, which explains their appearance in our protein interaction screen.  
Beside their role in epidermal cornification, SPRR proteins also fulfill an important role 
in the detoxification of ROS, both in the upper layers of the skin and throughout the whole 
body during tissue remodeling191,192. This is accentuated by the identification of numerous 
proteins with peroxiredoxin activity, protein disulfide isomerase or oxidoreductase activity, or 
thioredoxin peroxidase activity (Fig. 1, cluster II). All these GO terms mainly originated from 
the first elution fraction (disulfide group), in line with the ROS quenching of SPRR proteins 
via their cysteine residues192. It is interesting to mention that in clusters I and II most GO 
terms were upregulated both for SPRR1B and SPRR4 with the only exception of the 
thioredoxin activity (bar E) which was associated solely with SPRR1B and not with SPRR4. 
Thioredoxin has the ability to reduce inter- and intra-molecular S-S bonds28 and might as 
such promote SPRR1B protein turnover. Nevertheless, our previous analysis has indicated 
that SPRR4 is the better ROS quencher191.  Inter- and intramolecular disulfide bonds have 
also been detected in native CEs isolated from human skin191 proving that our in vitro 
screening procedure revealed physiologically relevant interactions. These interactions are 
reversible in vitro following β-mercaptoethanol treatment191. 
 
SPRR proteins function in DNA binding 
Besides the GO categories described above, other less expected molecular function 
terms appeared in our screen. Cluster III contains cytoskeletal binding proteins which appear 
to interact with both SPRR1B and SPRR4. These interactions are further substantiated by the 
fact that SPRR4 localizes to ordered fiber-like structures within the cytoplasm of OKF 
keratinocytes (Fig. 2A). Apparently, SPRR proteins are at least in close proximity to some 
cytoskeletal proteins. Both Pradervand et al.140 and Bonilla et al.13 have previously described 
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the localization of SPRR1 along actin structures. Although no direct physical interaction was 
detected, it was inferred that SPRR proteins might alter cytoskeletal functions and contribute 
to tissue remodeling13,140. Consistent with this, we recently showed that SPRR proteins 
indeed localize to membrane ruffles of migrating keratinocytes and play a major role in cell 
migration during wound healing192. 
The largest GO cluster comprises multiple categories which can all be described under 
the denomination “nucleic acid binding” (cluster V in Fig. 1 and Table 1). Due to the large 
diversity of proteins in this category it is likely that the interaction between SPRR and these 
proteins is indirect and mediated by mutual interaction of each of these proteins with DNA. 
Since most GO categories of cluster V were more enriched among SPRR4 as compared to 
SPRR1B interactors, the cellular localization of SPRR4 was analyzed in order to reveal its 
potential nucleic acid binding capacity. Immunofluorescence staining with a SPRR4 
monospecific antibody revealed minor but significant nuclear localization of SPRR4 proteins 
(Fig. 2A-C). In line with these results are earlier observations by other researchers who 
occasionally detected SPRR1, SPRR2, and SPRR3 proteins in the nucleus of cells by using 
various antibodies69,80,96,128,209. More recently, this was substantiated by live-cell-imaging of 
pEGFP-SPRR1B transfected keratinocytes where SPRR was consistently found in the nucleus 
of migrating cells192. This localization further highlights a potential role of SPRR proteins in 
DNA binding.  
Since the above described SPRR localization studies as well as the GO data were 
obtained in the contexts of a whole cell, it was important to assess the DNA binding 
properties of purified SPRR proteins directly in an in vitro assay with purified components. 
Addition of increasing amounts of purified SPRR4 protein to linear DNA fragments indeed 
resulted in a lower mobility of the DNA molecules in agarose gel (Fig. 3A), which is a 
measure for direct interaction between proteins and nucleic acids. Purified SPRR1, SPRR2, 
and SPRR3 proteins showed similar electrophoretic mobility shifts, although a 10 times 
higher molar excess of protein was required (results not shown). Interaction of SPRR4 with 
plasmid DNA was also detected via AFM analysis. Here multiple small protein dots decorating 
the DNA molecules can be observed (Fig. 3C), suggesting that SPRR proteins bind DNA in a 
sequence independent way. 
 
ROS affects SPRR protein multimerization and DNA binding  
Since the oxidation of SPRR proteins during ROS detoxification results in the 
reversible formation of both inter- and intramolecular S-S bonds191, we questioned whether 
these redox modifications can influence the DNA binding capacity of SPRRs. Analysis of the 
DNA binding activity of equal amounts of SPRR4, pre-treated with increasing concentrations 
of H2O2, revealed in a first instance a clear decrease in the DNA binding potential (Fig. 3D, 
lanes 1-5) suggesting an inverse relationship between SPRR protein multimerization and DNA 
binding. At higher H2O2 concentrations, less protein multimers were observed on PAGE (Fig. 
3E and F), while the DNA binding capacity increased. Mass spectrometric analysis of the 
different cysteine oxidation states revealed that at higher ROS levels disulfide bonds are 




explanation for a reversion to monomeric forms at higher H2O2 concentrations. Apparently 
only monomeric SPRR4 can bind efficiently to DNA. At the highest ROS levels, however, DNA 
binding is again reduced whereas the amount of monomers still increases. This is likely due 
to the generation of cysteine sulfinate/sulfonate adducts, which might counteract DNA 
binding because of their higher negative charge.  
 
 
Figure 4. Schematic representation of the impact of ROS on SPRR protein structure, cellular 
localization and molecular function. SPRR proteins are depicted by black disks. At normal ROS levels 
SPRR proteins are globally distributed within the cell both in nucleus and cytoplasm. At intermediate 
ROS levels, SPRR locates to the cell periphery and forms an efficient antioxidant barrier after 
multimerization due to cysteine oxidation while DNA binding decreases. At even higher ROS levels 













Our data are summarized in a model illustrating how ROS affects the activity and 
cellular localization of SPRR proteins (Fig. 4). Under normal culture conditions, at low ROS 
exposure, SPRR proteins are globally distributed across the cytoplasm and nucleus of cells. 
In this position SPRRs directly provide protection against ROS induced DNA breakage. At 
intermediate ROS levels, cysteine residues become oxidized and SPRR protein multimers are 
formed via disulfide bonding. The cellular localization is then shifted towards the cytoplasmic 
membrane and the DNA binding activity is reduced. While localized at the cell periphery, 
SPRR proteins form an efficient protective barrier against cell-infiltrating ROS, which are 
often produced at the cytoplasmic membrane via lipid peroxidation following UV exposure46. 
In this respect it is important to note that SPRRs were originally identified as UV inducible 
genes86. If the ROS levels are too high and exceed the natural reducing potential of the cell, 
major oxidative stress arises and the cysteine residues of SPRR proteins become further 
oxidized. As a result, SPRR converts back to a monomeric form and the DNA binding activity 
increases again. Such high ROS levels will eventually lead to cell death, and many of the 
apoptotic signaling pathways will become activated by redox modifications28,197. However, 
since DNA itself is a very efficient ROS quencher, DNA binding by SPRR might temporary 
delay DNA breakdown in order to provide antioxidant protection to neighboring cells. This 
compares to the normal situation in our skin where a layer of dead flattened cells protects 
the inner tissue against injurious external insults19. Apparently, the modulation of the 
oxidation state of SPRR proteins constitutes the basis for their selective antioxidant 
performance and fine-tunes their targeting to those cellular components that are most 
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Summary and general discussion 
 
The epidermis serves as a first line of defence against external insults, including toxic 
chemicals, bacterial/viral infections and solar UV radiation. A specialised structure within the 
cells of the outermost cornified layer, termed the cornified cell envelope (CE), is responsible 
for the mechanical and permeability properties of our skin. It consists of an extremely tough 
structure of cross-linked proteins and lipids, which still allows the high flexibility of our skin. 
Most of the identified CE proteins are transcribed from the epidermal differentiation complex 
(EDC), a 2.5 Mbp region on human chromosome 1q21. They include involucrin, loricrin, and 
the small proline-rich (SPRR) and LCE protein families. The head- and tail-domains of these 
CE precursor proteins are very similar and are utilised for transglutaminase cross-linking. The 
SPRR proteins are generally known as stress-inducible proteins. Following various forms of 
stress different SPRR family members are induced and subsequently modulate the skin’s 
barrier function. In this way, the CE provides protection specifically adjusted to the type of 
damage involved. 
All members of the SPRR gene family are tightly regulated at a transcriptional level. 
Each SPRR promoter sequence contains a complex panel of regulatory elements. In Chapter 
II, the biochemical cross-talk between the human Skn-1 isoforms is discussed. Two isoforms 
of this transcription factor, Skn-1a and Skn-1d1, were identified to bind the SPRR2A octamer 
site and activates its expression. Both isoforms bind the SPRR2A promoter region with similar 
affinity. Skn-1a functions cooperatively with Ese-1, an epithelial specific transcription factor 
previously shown to upregulate SPRR2A. However, this synergy was not found for Skn-1d1 
and is apparently dependent on the extra N-terminal domain of Skn-1a. This differential 
cross-talk of the different Skn-1 isoforms plays an important role in the fine-tuning of SPRR 
gene expression during the cornification process and its adaptation to stress.   
After disruption of the skin’s barrier by wounding major stress arises after which the 
surrounding tissue has to react rapidly to restore the barrier, avoid infections and prevent 
loss of blood or tissue degradation. In Chapter III we analysed SPRR expression in 
response to wounding. At the edge of the wound massive SPRR expression was found that 
exceeds the normal expression in the differentiated skin layers. During the wound healing 
process reactive oxygen species (ROS) are generated as chemical steriliser against invading 
bacteria. In general, ROS are considered as toxic compounds as they can damage DNA, 
proteins, and lipids. As such, they are essential determinants of the ageing process and are 
involved in many human diseases, including Alzheimer, Parkinson, diabetes, and cancer. 
However, ROS are also naturally produced as signalling molecules which initiate the healing 
process. The local increase of ROS levels signal to the immune system to attract leukocytes. 
Subsequently, SPRR proteins directly reduce ROS levels via their cysteine residues. In this 
way, the tissue is protected from ROS induced damage but more importantly cell migration is 
allowed for proper wound closure. We identified SPRR as essential players in the wound 
healing process since its downregulation inhibited cell migration. This novel function is not 
only important following cutaneous wounding but plays a key role in all major tissues after 




Also non-wounded skin is continuously challenged by ROS. Solar UV radiation, toxic 
chemicals, air pollutants and bacterial/viral infections can all increase ROS. To cope with high 
ROS levels, the epidermis contains several cellular defence mechanisms. Multiple ROS-
detoxifying enzymes, transcriptionally activated by Nrf2, and numerous low molecular weight 
antioxidants are gradually present in the different skin layers. During the cornification 
process, these groups of antioxidants are increased and subsequently intracellular ROS levels 
are reduced. Since SPRR proteins can actively reduce ROS, we questioned whether they 
could still fulfil this function after cross-linking within the CE (Chapter IV). Indeed, both 
purified SPRR proteins and CEs isolated from native skin significantly lowered ROS levels. 
Hence, the SPRR proteins within the CE constitute our first line of antioxidant defence. Upon 
oxidation SPRR proteins form both inter- and intramolecular disulfide bonds, which were also 
identified within the CE by mass spectrometry. Also the CE proteins fillagrin-2, KPRP, and 
loricrin were identified in this assay. Loricrin is a major component of the CE with a higher 
cysteine content than SPRRs. However, it contains a lower antioxidant potential compared to 
the individual SPRR proteins. Apparently, the number of cysteine residues per protein does 
not define its antioxidant potential which is more likely determined by structural differences. 
This also confirms the superior antioxidant properties of SPRR4. UV irradiation was 
previously shown to specifically induced SPRR4 expression. As a result, the CE properties are 
altered and the cornified layer is thickened. The upregulation of SPRR4 in response to UV 
results in adaptation of the skin’s barrier and increases its antioxidant defence. These 
findings add, besides the mechanical and permeability properties of the CE, a highly adaptive 
and protective antioxidant shield to the skin’s barrier. 
In Chapter V we have examined the molecular mechanisms behind the protective 
antioxidant function of SPRR. Proteomic analysis of SPRR interaction partners identified 
known CE precursor proteins and proteins involved in the antioxidant response. This is in line 
with their established function in skin cornification and the newly identified protective 
function against ROS. Furthermore, proteins involved in cytoskeletal binding were identified, 
which reflects the function of SPRR in cell migration. Finally, multiple nucleic acid binding 
proteins were identified. DNA binding of SPRR, which occurs likely in a sequence 
independent manner, was confirmed and visualised by the use of several in vitro assays 
(bandshift analysis and AFM). Interestingly, ROS can modulate the SPRR protein activity and 
influence its DNA binding properties. Under normal conditions, at low ROS exposure, SPRR 
can bind DNA and prevent ROS-induced DNA damage. During oxidative stress, cysteine 
residues of SPRR become oxidised, protein multimerization occurs, DNA binding is reduced 
and its localisation is shifted from the nucleus to the cell periphery. While localising at the 
cytoplasmic membrane, SPRR proteins form a flexible antioxidant barrier, comparable to 
their role at the migrating front during wound healing. Apparently, modulating the oxidation 
state of SPRR proteins constitutes the basis for their global antioxidant performance. The 
skin’s barrier can in this way be efficiently fine-tuned and adapted to specific tissue 





















Elk organisme, van een vis tot een plant en van een bacterie tot de mens, heeft om 
te kunnen overleven een beschermende barrière nodig tegen invloeden van buitenaf. De 
epidermis is het buitenste deel van onze huid en is verantwoordelijk voor deze 
barrièrefunctie. De epidermis is opgebouwd uit meerdere lagen en biedt ons bescherming 
tegen o.a. mechanische stress, bacterie- en virusinfecties, schadelijke chemicaliën en 
uitdroging. Van binnenuit wordt de epidermis continu vernieuwd door delende, migrerende 
en differentiërende keratinocyten. Na de celdeling van een keratinocyte blijft er één cel 
achter in de basale, meest interne laag van de epidermis en begint de andere aan het 
cornificatieproces. Dit proces wordt ook wel terminale differentiatie genoemd, omdat de cel 
omhoog migreert via de bovenliggende huidlagen, sterk verandert van morfologie en 
eiwitsamenstelling, en eindigt als ‘dode’ huidschilfer in de hoornlaag. De “small proline-rich” 
ofwel SPRR-eiwitten spelen een belangrijke rol tijdens het cornificatieproces. Samen met 
enkele andere eiwitten worden zij aan de binnenkant van de celmembraan samengeketend 
tot een complexe stevige structuur, de zogenoemde “cornified cell envelope” (CE). Door de 
CE is onze huid sterk maar tegelijkertijd zeer flexibel. De expressie van de SPRR-eiwitten kan 
worden verhoogd door stress, variërend van zonlicht tot een huidinfectie. Dit resulteert in 
een toename van de hoeveelheid SPRR in de CE, en daarmee in een versterkte 
barrièrefunctie van de huid. De rol van de SPRR-eiwitten binnen het cornificatieproces 
alsmede de recentelijk gevonden expressie van SPRR-eiwitten in diverse weefsels en 
organen is beschreven in Hoofdstuk I. 
 Doordat diverse soorten stress de concentratie van specifieke SPRR-eiwitten kunnen 
reguleren, is er veel onderzoek gedaan naar de promotor-regio van de verschillende SPRR’s. 
Elke SPRR-promotorsequentie bevat een complexe mix van verscheidene bindingsites voor 
transcriptiefactoren. In Hoofdstuk II is de regulatie van SPRR2A door de Skn-1 
transcriptiefactoren onderzocht. Zowel Skn-1a als de verkorte isovorm Skn-1d1 bindt met 
vergelijkbare affiniteit aan de promotorsequentie van SPRR2A. Alleen de combinatie van Skn-
1a met Ese-1, een tweede zeer bekende transcriptiefactor, zorgt voor een versterkte 
expressie van SPRR2A. De verschillen tussen de twee Skn-1 isovormen spelen een 
belangrijke rol bij de fine-tuning van de benodigde hoeveelheid SPRR tijdens het 
cornificatieproces en de adaptatie van de huidbarrière tegen stress.  
 Na verwonding van de huid is de beschermende barrièrefunctie sterk verzwakt. Dit 
resulteert in een enorme hoeveelheid stress in de huid, leidt mogelijk tot bloed- en 
weefselverlies en vergroot de kans op infecties. Het weefsel rondom de wond moet dan ook 
zeer snel reageren om de barrièrefunctie te herstellen. In Hoofdstuk III hebben wij de 
expressie van SPRR-eiwitten tijdens wondgenezing bestudeerd. Precies aan de rand van een 
wond was de hoeveelheid SPRR sterk verhoogd en was deze zelfs veel hoger dan in de 
normaal gedifferentieerde huid. Tijdens het genezingsproces worden direct na verwonding 
grote hoeveelheden zuurstofradicalen aangemaakt als chemische sterilisatie tegen bacteriën. 
Naast de zuurstof die wij inademen en nodig hebben om te overleven, bestaan er ook 
diverse reactieve vormen van zuurstof. Over het algemeen worden deze zuurstofradicalen 




zijn zuurstofradicalen een oorzaak van het verouderingsproces. Ook zijn ze direct betrokken 
bij diverse humane ziekten, zoals Alzheimer, Parkinson, suikerziekte en kanker. Echter, 
tijdens het begin van het genezingsproces spelen zuurstofradicalen ook een belangrijke rol 
bij de signaaltransductie naar het immuunsysteem en zorgen dat witte bloedlichaampjes 
(leukocyten) de exacte locatie van de wond weten te vinden. Vervolgens zorgen de SPRR-
eiwitten, via enkele cysteïne-residuen, voor een verlaging van de hoeveelheid radicalen om 
zo het omliggende weefsel te beschermen tegen de schade ervan. Ook is deze verlaging 
noodzakelijk voor celmigratie en dus het dichten van de wond. De SPRR-eiwitten bleken 
essentieel te zijn in het genezingsproces, want wanneer we specifiek de hoeveelheid SPRR 
verlaagden, werd de celmigratie sterk geremd. Deze nieuw ontdekte functie van SPRR is niet 
alleen zeer belangrijk voor de huid, maar ook in alle andere weefsels na verschillende 
soorten letsel, variërend van regeneratie na zenuwschade tot het herstel na een hartaanval. 
 Ook zonder verwonding wordt de huid vaak blootgesteld aan zuurstofradicalen. O.a. 
zonlicht, schadelijke chemicaliën, luchtvervuiling, bacterie- en virusinfecties kunnen de 
productie van zuurstofradicalen induceren. Als bescherming bevat de epidermis diverse 
cellulaire afweermechanismen, waaronder verschillende enzymen en antioxidanten. Tijdens 
het cornificatieproces stijgt de expressie van beide groepen om de hoeveelheid radicalen te 
verlagen. Doordat we voor SPRR een vergelijkbare functie tijdens het wondgenezingsproces 
hebben gevonden, vroegen wij ons af of de verschillende SPRR-eiwitten ook als antioxidant 
kunnen werken terwijl ze vast geketend zijn in de CE (Hoofdstuk IV). Uit onze resultaten 
blijkt inderdaad dat zowel gezuiverde SPRR-eiwitten als ook uit de huid geïsoleerde CE’s de 
hoeveelheid radicalen significant verlagen. De SPRR-eiwitten zorgen ervoor dat de buitenste 
laag van dode huidcellen zelf de eerste verdedigingslinie tegen oxidanten vormt. In hun 
antioxidantfunctie oxideren de cysteïne-residuen in SPRR en vormen ze inter- en 
intramoleculaire disulfidebruggen. Dit zijn omkeerbare verbindingen binnen een 
eiwitstructuur. Ook in de CE hebben we deze voor SPRR en enkele andere bekende CE-
eiwitten teruggevonden. Eén ervan is loricrin, een belangrijk en veelvoorkomend eiwit in de 
CE. Het bevat meer cysteïnes dan de verschillende SPRR-eiwitten, maar toch is loricrin een 
veel zwakkere antioxidant. Blijkbaar is niet zozeer het aantal cysteïne-residuen van belang, 
maar wordt de antioxidant-werking bepaald door de verschillen in eiwitstructuur. Dit 
bevestigt ook de superieure antioxidantsterkte van SPRR4. In ons laboratorium is eerder 
aangetoond dat UV-bestraling zorgt voor een specifieke inductie van SPRR4-expressie. Als 
gevolg daarvan veranderen de eigenschappen van de CE en ontstaat er een verdikking van 
de huid. De inductie van SPRR4 na UV resulteert in een aanpassing van de barrièrefunctie 
van de huid en verhoogt de antioxidantcapaciteit ervan. Naast de mechanische- en 
permeabiliteitfunctie van de CE voegen de SPRR-eiwitten ook een sterk adaptieve en 
beschermende antioxidatiefunctie toe aan de barrièrefunctie van de huid. 
In Hoofdstuk V zijn wij dieper in gegaan op het moleculaire mechanisme achter de 
beschermende antioxidatiefunctie van de SPRR-eiwitten. Tijdens deze studie hebben wij 
diverse potentiële SPRR-bindende eiwitten geïdentificeerd. Enkele ervan spelen een bekende 
rol in het cornificatieproces of fungeren als antioxidant, wat in overeenkomst is met de 
bewezen functie in de huid van de SPRR-eiwitten, en met de recentelijk ontdekte 
beschermende rol tegen zuurstofradicalen. Verder zijn diverse cytoskelet-bindende eiwitten 




nucleïnezuur-bindende eiwitten geïdentificeerd. Aan de hand van deze resultaten 
voorspelden we dat SPRR mogelijk zelf aan DNA zou kunnen binden, wat inderdaad 
bevestigd werd door diverse experimenten. Ook vonden we dat de DNA-bindingscapaciteit 
van SPRR kan worden beïnvloed door zuurstofradicalen. Onder normale omstandigheden, bij 
een lage hoeveelheid radicalen, kan SPRR aan het DNA binden en voorkomt het schade aan 
DNA door zuurstofradicalen. Tijdens oxidatieve stress worden de cysteïne-residuen van SPRR 
geoxideerd en vormt het eiwit disulfidebruggen. De DNA-bindingscapaciteit wordt 
verminderd en de lokalisatie van SPRR verschuift van de kern naar de rand van de cel. Hier 
vormt SPRR een flexibele verdedigingslinie tegen zuurstofradicalen, die vergelijkbaar is met 
de lokalisatie van SPRR tijdens celmigratie bij het wondgenezingsproces. Blijkbaar vormt de 
oxidatietoestand van SPRR de basis voor de antioxidantfunctie ervan. Op deze manier kan 
ook de barrièrefunctie van de huid efficiënt worden aangepast om een optimale bescherming 
tegen zuurstofradicalen te bieden.  
Al in 1851 heeft de Duitse professor Joseph von Gerlach bewezen dat de mens ook 
zuurstof via de huid kan opnemen. 160 jaar later, is het ons gelukt om voor het eerst de 
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